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In clinical studies of time to event data, non-proportional hazards are very com-
mon. The Cox model is frequently used assuming that the treatment effect is either
constant over time or a specific function of time. However, it is difficult to deter-
mine whether the form chosen for the treatment effect is correct. Even if the correct
form is chosen, the cumulative treatment effect is often preferred over treatment ef-
fect on the hazard function in many applications. For example, clinicians are often
interested in comparing the 5-year survival between the treatment groups. In the
presence of non-proportional hazards, survival or cumulative hazard curves can be
compared using non-parametric estimators such as the Nelson-Aalen (Nelson, 1972;
Aalen, 1978) or Kaplan-Meier (Kaplan and Meier, 1958) estimator. These estimators
will lead to biased treatment comparisons in the presence of confounders, as is often
the case in observational studies.
Several methods have been proposed to estimate cumulative treatment effects.
Doksum and Song (1989) introduced a relative change function in terms of cumu-
lative hazards to compare two groups. Confidence bands were constructed under a
proportional hazards assumption. Parzen, Wei and Ying (1997) examined the dif-
ference between two survival functions and constructed confidence bands based on
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simulation techniques. McKeague and Zhao (2002) proposed the ratio of survival
functions as a treatment effect measure and constructed simultaneous confidence
bands using empirical likelihood. Kalbfleisch and Prentice (1981) estimated an av-
erage hazard ratio, averaged with respect to a weight function.
Each of the above listed methods are not suitable for observational data since
they do not accommodate the adjustment of potential confounders. In the context
of semiparametric models which adjust for covariates, Schemper (1992) examined
the estimation of the average hazard ratio for two populations through a weighted
Cox model. Xu and O’Quigley (2000) estimated the average regression effect under
a non-proportional hazards model with time-varying regression coefficients, with a
weighted score equation used to obtain a consistent estimator.
In this dissertation, we develop three novel methods to estimate cumulative treat-
ment effects. In Chapter 2, we utilize a stratified Cox model, but with treatment
groups serving as strata. The ratio of cumulative hazards between each treatment
and the reference group is estimated. Through the use of a treatment-stratified Cox
model, the functional form of the treatment effect does not need to be specified,
while adjustment for potential confounders is achieved through a model. With time-
constant adjustment covariates, the proposed measure can be reduced to a ratio
of baseline cumulative hazards, which can be estimated by the method of Breslow
(1972). When proportional hazards holds for the treatment effect, our measure con-
verges to the commonly used hazard ratio. Our proposed estimator is proved to
follow a Gaussian process, with a variance estimator in an explicit form derived
using the theory of empirical processes.
The method proposed in Chapter 2 assumes that the adjustment covariate ef-
fects follow proportional hazards. When proportional hazards does not hold, the
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functional forms of these effects need to be specified. In Chapter 3, we propose an
inverse probability of treatment weighting (IPTW) method to balance the distri-
bution of confounders among treatment groups. Three measures are developed to
quantify the cumulative treatment effects, contrasting treatment-specific cumulative
hazards, probability of death, and restricted mean lifetime. These measures were
estimated using non-parametric estimators derived from weighted Nelson-Aalen es-
timators (Nelson 1972, Aalen, 1978). The probability of treatment assignment given
the potential confounders is estimated through a generalized logit model. After
applying IPTW, pusedo populations are created among treatment categories. The
distribution of confounders for each of these populations is the same as the entire
population. The weighted measures contrast the scenario wherein the treatment is
applied to the entire population, to the scenario where the reference treatment is ap-
plied. The proposed estimators are proved to follow a Gaussian process with explicit
variance estimators derived using empirical process theory.
The IPTW method has been applied in many applications. Brumback, Hernan
& Robins (2000) estimated the causal effect of time-dependent exposure adjusting
for time-dependent confounders using marginal structural models. In their setting,
there exists a time-dependent covariate that is a risk factor for mortality and also
predicts subsequent exposure, and past exposure is predictive of this covariate. A
inverse weight was applied in order to obtain the true causal effect of exposure.
The inverse weight is time-dependent, depending on the treatment and confounder
history. Hernan, Brumback & Robins (2000) extended the above work to analyze
time to event data. A proportional hazard Cox model was assumed, adjusting for
the covariates at baseline. A time-dependent inverse weight was applied to obtain
the causal effect of treatment. Xie and Liu (2005) developed an IPTW Kaplan-Meier
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estimator, with a weighted log rank test proposed to examine the treatment effects.
Current methods in estimating the cumulative effect in the context of time to
event data usually focus on the survival or cumulative hazard function. However,
mean lifetime is more relevant in many areas of medicine, particularly for organ
failure patients. For example, in the U.S., a proposed liver allocation system would
rank the patients on the waiting list by difference in 5-year restricted mean lifetime.
Chen & Tsiatis (2001) compared the restricted mean lifetime between two treatment
groups with Cox proportional hazards models assumed for each treatment group.
The survival function for each group is estimated by explicitly averaging over all
subjects in the sample. We also propose a difference in restricted mean lifetime in
Chapter 3, but using weighted non-parametric estimators. Unlike the method by
Chen & Tsiatis (2001), we balance the distribution of confounders through IPTW
so that functional forms of the confounding effects do not need to be specified.
The methods proposed in Chapter 2 and Chapter 3 were illustrated through the
comparison of peritoneal dialysis and hemodialysis therapy for patients with end-
stage renal disease (ESRD). The cumulative treatment effect is examined using each
of the above proposed measures.
Censoring times are assumed to be independent of event times given treatment
in Chapter 3. When censoring time depends on risk factors for the event, event
and censoring times will be correlated through such factors. If these factors are
time-dependent and they are not only risk factors for the event but also affected by
treatment, standard methods adjusting for these time-dependent factors may pro-
duce biased treatment effects. However, if baseline values instead of time-dependent
factors are adjusted, dependent censoring may be an issue. Standard hazard regres-
sion methods, such as the Cox model, generally assume that event and censoring are
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independent given the adjustment covariates.
The inverse probability of censoring weighing (IPCW) method has been proposed
to handle the dependent censoring. This method was originally developed by Robins
and Rotnitzky (1992) and Robins (1993). A Cox proportional hazards model is
assumed for the event time. An inverse probability of censoring weight is applied
in the estimating equation for the effect parameters. This weight is the inverse of
the survival function for censoring. After applying the inverse censoring weight, the
estimators converge to the same measures as in the case of independent censoring.
Robins and Finkelstein (2000) applied IPCW to overcome dependent censoring in
an AIDS clinical trial. Matsuyama and Yamaguchi (2008) estimated the marginal
survival time in the presence of dependent competing risks, using IPCW to handle
the dependent censoring. Yoshida, Matsuyama and Ohashi (2007) estimated the
treatment effect using a Cox proportional hazards model, again applying IPCW.
In Chapter 4, we extend the methods proposed in Chapter 3 to accommodate
dependent censoring. We develop estimators which combine IPTW (to balance the
treatment groups with respect to baseline confounders) and IPCW (to handle the
dependent censoring induced by time-dependent variates not captured by IPTW).
Comparing our works to that of Yoshida, Matsuyama and Ohashi (2007), our meth-
ods do not need to assume proportional hazards for the adjustment covariates. Our
weighted estimators are proved to converge to Gaussian processes and closed-form
covariance function estimators are developed. Our methods proposed in Chapter 4
are applied to the comparison of wait-list survival between race groups (Caucasian
vs. African American) for patients with end-stage renal disease.
CHAPTER II
Estimating Cumulative Treatment Effects In The Presence
Of Non-proportional Hazards
ABSTRACT: Often in medical studies of time to an event, the treatment effect is
not constant over time. In the context of Cox regression modeling, the most frequent
solution is to apply a model that assumes the treatment effect is either piece-wise
constant or varies smoothly over time; i.e., the Cox non-proportional hazards model.
This approach has at least two major limitations. First, it is generally difficult to as-
sess whether the parametric form chosen for the treatment effect is correct. Second,
in the presence of non-proportional hazards, investigators are usually more interested
in the cumulative than the instantaneous treatment effect (e.g., determining if and
when the survival functions cross). Therefore, we propose an estimator for the aggre-
gate treatment effect in the presence of non-proportional hazards. Our estimator is
based on the treatment-specific baseline cumulative hazards estimated under a strat-
ified Cox model. No functional form for the non-proportionality need be assumed.
Asymptotic properties of the proposed estimators are derived, and the finite-sample
properties are assessed in simulation studies. Pointwise and simultaneous confidence
bands of the estimator can be computed. The proposed method is applied to data
from a national organ failure registry.
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2.1 Introduction
In medical studies featuring survival time data, non-proportional hazards are very
common. In Cox (1972) regression modeling, the most frequent solution is to apply
a model that assumes that the treatment effect is either piecewise constant or varies
smoothly over time. However, it is generally difficult to assess whether the parametric
form chosen for the treatment effect is correct. Even if the correct form is chosen,
investigators are usually more interested in the cumulative than the instantaneous
treatment effect. This is particularly true in settings where the hazard ratio changes
direction over time, in which case researchers are often interested in if and when
the two survival curves cross. Therefore, we propose an estimator of the cumulative
treatment effect under non-proportional hazards. Under our proposed method, the
treatment effect is viewed as a process that unfolds over time and is measured by
the ratio of cumulative hazards; no functional form need be assumed for the non-
proportionality.
The analysis that motivated our research aims to compare survival of end-stage
renal disease patients on two dialysis methods: hemodialysis (HD) and peritoneal
dialysis (PD). Peritoneal dialysis is less expensive than HD, but newer and hence
less established; PD has long been suspected of providing reduced survival relative to
HD. The debate over PD versus HD is one of the most contentious issues in medicine
and, helping to fuel the debate, previous studies have produced conflicting results
(Bloembergen et al., 1995; Fenton et al., 1997). Fenton et al. (1997) compared PD
to HD using non-proportional hazards models assuming a piece-wise constant hazard
8
ratio. The authors found that hazard ratios (PD versus HD) is significantly decreased
early in the follow-up period, but that the effect changed direction later on. Since the
cumulative effect was not evaluated, one cannot tell which therapy is better in terms
of survival based on their results. Applying our method to national registry data,
we compare PD and HD covariate-adjusted survival, without assuming proportional
hazards. We can estimate the time-dependent cumulative effect of PD relative to HD
on mortality without assuming any functional form for that effect. The treatment
effect is viewed as a process over time, which is reflected by our inference procedures.
Several methods have been proposed for the comparison of survival or cumulative
hazard functions in nonparametric settings. Dabrowska, Doksum and Song (1989)
introduced a relative change function involving the survival functions for two popula-
tions and constructed pointwise confidence intervals. Simultaneous confidence bands
for this function were constructed under a proportional hazards assumption. Parzen,
Wei and Ying (1997) constructed simulation-based confidence bands for the difference
of survival functions. McKeague and Zhao (2002) derived simultaneous confidence
bands for ratios of survival functions based on empirical likelihood. Kalbfleisch and
Prentice (1981) estimated an average hazard ratio using a weight function. Since
each of the above methods was designed for nonparametric settings, they would be
suitable for randomized clinical trials but would generally not apply to observational
data where covariate adjustment is required. In the context of covariate adjustment,
Schemper (1992) suggested the estimation of average hazard ratio of the two pop-
ulations through a weighted Cox model. Xu and O’Quigley (2000) estimated the
average regression effect through weighted score equation, under a non-proportional
hazard model with time-varying regression coefficients.
In this chapter, we propose an estimator based on the treatment-specific baseline
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cumulative hazards estimated under a stratified Cox model. The treatment effect
is viewed as a process that unfolds over time, and can be related directly to the
treatment-specific survival functions. Pointwise confidence intervals and simultane-
ous confidence bands of our estimator are constructed.
The remainder of this chapter is organized as follows. In the next section, the
proposed measure and its estimator are described. We develop the asymptotic prop-
erties of the proposed estimator in Section 2.3. Section 2.4 evaluates the applicability
of the derived asymptotic results to finite samples through simulation. In Section
2.5, we apply our proposed method to compare survival on hemodialysis and peri-
toneal dialysis using data from a national organ failure registry. We provide some
discussion of the proposed and related methods in Section 2.6.
2.2 Proposed methods
We first set up the notation used throughout the article. Let J+1 be the number of
treatment groups (numbered j = 0, 1, . . . , J), where the first group (j=0) represents
a reference category to which the remaining treatment groups are compared. The
total number of subjects is denoted by n. Let Ti be the survival time for subject i.
The survival time of a subject is potentially right censored, with censoring time given
by Ci. The observation time and observed event indicator are given by Xi = Ti ∧Ci
and ∆i = I(Ti ≤ Ci), respectively, where a ∧ b = min{a, b} and I(A) is an indicator
function taking the value 1 when condition A holds and 0 otherwise. The event
counting processes are defined as Ni(t) = ∆iI(Xi ≤ t). The risk indicators are
denoted by Yi(t) = I(Xi ≥ t). Let Gi denote the treatment group for subject i and
Gij = I(Gi = j). Correspondingly, we set Yij(t) = Yi(t)Gij and dNij(t) = dNi(t)Gij .
The observed data consist of n independent vectors, (Xi, ∆i, Gi,Zi), where Zi is a
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vector of adjustment covariates.
We assume that Ti follows a stratified Cox model, with hazard function
λij(t) = λi(t|Gi = j) = λ0j(t) exp{β
T
0 Zi},(2.1)
where λ0j(t) is an unspecified treatment-specific baseline hazard function, and β0 is
an unknown parameter vector. Under (2.1), proportionality of the hazard functions
is not assumed to hold across treatment groups, but is assumed with respect to the
adjustment covariates. Note that in the set-up we consider, the adjustment covariates
vector is treated as time-constant. We revisit the issue of time-dependent covariates
in Section 2.6.
The partial likelihood (Cox, 1975) estimator of β0 is denoted by β̂, and is given









Zi − Zj(t, β)
}
dNij(t),













TZi} for d = 0, 1, 2, where a
⊗0 = 1, a⊗1 =
a and a⊗2 = aaT for a vector a. The quantity τ satisfies P (Xi > τ) > 0 and would
ordinarily be set to the maximum observation time such that all observed events are
included in the analysis.









λ0j(s)ds is the cumulative baseline hazard for treatment group j.
Under (2.1), θj(t) can be used as a measure of the aggregate treatment effect across









That is, contrasting patients who have the same covariate pattern but receive dif-
ferent treatments, the ratio of cumulative hazards and ratio of baseline cumulative
hazards are equal. Note also that the proposed cumulative hazard ratio reduces to
the hazard ratio if proportionality holds. That is, if proportionality holds across the
treatment groups, such that the model λij(t) = λ0(t) exp{ρj + β
T




In this light, one could view the proposed ratio of cumulative hazards as a general-
ization of the familiar hazard ratio.




, for j = 1, · · · , J, t ∈ [tL, tU ],(2.3)
where tL is chosen sufficiently large to avoid the situation where Λ̂00(tL, β̂) = 0, while
tU is chosen to avoid well-known instability that exists in the tail of the observation
time distribution. The cumulative baseline hazards can be estimated through the













In the next section, we derive the asymptotic properties of the proposed estimator.
2.3 Asymptotic properties
To derive the large-sample properties of θ̂j(t), we assume the following regularity
conditions for i = 1, · · · , n and j = 0, · · · , J .
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(a) (Xi, ∆i, Gi,Zi) are independent and identically distributed random vectors.
(b) Zik have bounded total variation; i.e., |Zik| < κ for all i = 1, · · · , n and k =




λ0(t)dt < ∞ where τ is a pre-specified time point.
(d) Continuity of the following functions:
s
(1)





j (t, β), s
(2)








j (t, β) is the limiting value of S
(d)
j (t, β) for d = 0, 1, 2, with s
(1)
j (t, β) and
s
(2)
j (t, β) bounded and s
(0)
j (t, β) bounded away from 0 for t ∈ [0, τ ] and β in an open
set.













j (t, β) − zj(t, β)
⊗2,




j (t, β) is the limiting value of Zj(t, β).
(f) P (Gij = 1) > 0.
The asymptotic behavior of our estimator is summarized by the following two
theorems.
THEOREM 1. Under conditions (a) to (f), θ̂j(t) converges to θj(t) almost surely
and uniformly for t ∈ [τL, τU ].
The consistency of θ̂j(t) follows from the uniform consistency of Λ̂0j(t, β̂), Λ̂00(t, β̂),
and β̂ as well as the Functional Delta Method (Pollard, 1990) and various results
from empirical processes theory (Bilias, Gu and Ying, 1997).
THEOREM 2. Under conditions (a) to (f), n1/2[θ̂j(t)−θj(t)] converges asymptoti-










Φij(t, β) = hj















{Zi − zj(t, β)} dMij(t, β),(2.8)
dMij(t, β) = dNij(t) − Yij(t) exp{β
TZi}dΛ0j(t).(2.9)
The covariance function can be consistently estimated by σ̂j(s, t, β̂) where:






with ξ̂ij(t, β̂) obtained by replacing all limiting values in ξij(t, β0) with their empirical
counterparts.
The asymptotic normality of n1/2[θ̂j(t) − θj(t)] can be proved by first writing















The quantity {Λ̂00(t, β̂)
−1
− Λ00(t)
−1} can be written as a function of {Λ̂00(t, β̂) −
Λ00(t)} by using the Functional Delta Method. The proof involves decomposing
{Λ̂0j(t, β̂)−Λ0j(t)} into {Λ̂0j(t, β̂)− Λ̂0j(t, β0)}+ {Λ̂0j(t, β0)−Λ0j(t)}. The Central
Limit Theorem and various results from the theory of empirical processes are applied
in the proof, which is outlined in the Web Appendix A.
Some comments on model misspecification are in order. If model (2.1) is mis-
specified, Lin and Wei (1989) demonstrated that β̂ converges to a vector β∗ 6= β0.
Further, if the true model is λij(t) = λ0j(t) exp{β
T
0 f(Zi)}, while the assumed model
is λij(t) = λ
∗
0j(t) exp{β
T g(Zi)}, where f(Zi) and g(Zi) are functions of covariates
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Zi, under a misspecified model, Λ̂0j(t) (Gerds and Schumacher, 2001) converges to
Λ∗0j(t) 6= Λ0j(t). We examine this issue numerically in Section 2.4.
In certain situations, investigators will want to estimate θj(t) at a pre-specified
value, t = t0 (e.g., 1 year, 5 years, etc). In these cases, inference could be based on a
Wald-type test since n1/2[θ̂j(t0)−θj(t0)]σj(t0)
−1 will asymptotically follow a standard
normal distribution, with σ2j (t) ≡ σj(t, t). However, in many practical applications,
it makes more sense to view θj(t) as a process over time, and this view should be
captured by the corresponding inference procedures. For instance, in our motivating
example, based on analyses reported in the literature, we anticipate that the effect
of PD (vs. HD) will depend on time and there is no single specific time point at
which we wish to conduct our inference. Lin, Fleming and Wei (1994) proposed a
method to construct simultaneous confidence bands for survival curve under the Cox
model. We extend this to our estimator. The idea is to approximate the normalized
distribution of Q̂(t) = n1/2[θ̂j(t)− θj(t)] for t ∈ [tL, tU ] by a zero-mean Gaussian pro-
cess Q̃(t) = n−1/2
∑n
i=1 ξ̂ij(t, β̂)Ri, where Ri is a standard normal random variable.
The distribution of Q̂(t) is generated through simulation by repeatedly generating
independent standard normal random samples Ri(i = 1, · · · , n). To avoid the result-





, whose distribution can be approximated by Q̂(t)/θ̂j(t)
after applying the Functional Delta Method. In addition, a weight function, w(t),
is chosen to adjust the width of the band at different time points. By using weight
function, w(t) = θ̂j(t)/σ̂(t), suggested by Nair (1984) and the previously-described
















With the log-transformation, a 100(1 − α)% simultaneous confidence band for θj(t)






The finite sample properties of the proposed estimator were evaluated through
a series of simulation studies. For convenience, we consider two treatment groups.










for i = 1, · · · , n and j = 0, 1, where Ui is a Uniform(0,1) random variable, β0 = 0.5,
and Zi is a bivariate vector with each element following a Bernoulli (0.5) distribution.
This set-up implies that Ti follows a Weibull model with hazard function
λij(t) = λi(t|Gi = j) = αjγjt
γj−1 exp{βT0 Zi}.
Non-proportionality of the hazard functions for groups 0 and 1 is induced when
γ1 6= γ0. Various values of γj were used to make the hazard ratio constant, decrease,
and increase through time. Censoring times were generated from a Uniform(τ/2, τ)
distribution with τ = 5. Different values of αj were used to vary the percent of
censoring (denoted by C%). For each data configuration, the no-censoring setting
was also examined. We varied the sample size as n=50, 100, 200, 500, and each
data configuration was replicated 1,000 times. We compared the ratio of cumulative
hazard to its true value at the 75th percentile of the observation time distribution,
which we denote by t0.75. Results are shown in Table 2.1 and Table 2.2.
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The proposed estimator generally performs well in finite samples, n=100, 200,
500 (Table 2.1). Even in the presence of a very high proportion of censoring, the
empirical mean of θ̂1(t) is approximately unbiased for sample sizes of n=500 and
n=200, and almost all simulations with size of n=100. In general, the bias is reduced
as the number of subjects in each treatment group increases. The average asymptotic
standard error (ASE) is generally close to the empirical standard deviation (ESD),
while the empirical coverage probabilities (CP) are consistent with the nominal value
of 0.95.
For smaller sample sizes (e.g., n = 50), the bias of θ̂1 is relatively large and the
coverage probabilities are notably lower than the nominal value of 0.95 (Table 2.2).
However, if log θ̂1(t0.75) is considered, the bias reduces dramatically and the coverage
probability is quite good. Therefore, when the sample size is very small (e.g., n = 50),
inference should be based on log θ1(t).
We also looked at the performance of our estimator at various percentiles of the
observation time distribution. The scenario where the hazard ratio increases with
time and sample size n=500 are considered. We find that our estimator is approxi-
mately unbiased even at the 10th and 90th percentiles of the observation distribution
and that the coverage probabilities are close to the nominal value of 0.95 (Table 2.3).
We explored the performance of our estimator and its variance under models with
functional misspecification and incorrect covariate adjustment (results not shown).
We find that under a misspecified model, the proposed estimator is biased, although
the bias is relatively small; as well, the ASE is close to the ESD.
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2.5 Analysis of dialysis data
We applied our proposed methods to compare patient survival on hemodialysis
(HD) and peritoneal dialysis (PD). Hemodialysis served as the reference category
(j=0), while PD was labeled as j=1. Hence, the parameter of interest is θ1(t), which
contrasts the cumulative hazard for PD relative to HD. Data were obtained from
the Canadian Organ Replacement Register (CORR), a nation-wide and population-
based organ failure registry which is maintained by the Canadian Institute for Health
Information. The mortality hazard on dialysis was investigated for End Stage Renal
Disease (ESRD) patients who were either on HD or PD at the time of renal replace-
ment therapy initiation. The dialysis method is inherently time-dependent since
a patient may switch therapies. We carried out two separate analyses. The first
analysis, in the spirit of an intent-to-treat (ITT) analysis, classified patients based
on first method of dialysis; that is, the type of dialysis received at the initiation of
renal replacement therapy. The ITT analysis compares the risk of death between pa-
tients initially placed on PD (vs. HD) knowing that patients may switch therapies.
The second analysis censored the follow-up time at the first dialysis therapy switch
(CAFS). The CAFS analysis compares the risk of death for patients who stay on PD
to patients who remain on HD.
The study population included n=23,254 registered patients aged 18 and above
who initiated dialysis between 1990 and 1998. Patients began follow-up at the date
of dialysis initiation and were followed until the earliest of death, loss to follow-up,
kidney transplantation or the end of the observation period (December 31, 1998).
For the ITT analysis, approximately 38% of HD patients (n0=17,766) were observed
to die, while 36% of patients on PD (n1=5,488) died. For the CAFS analysis, the
18
proportion observed to die for patients on HD was approximately 30% and 25% for
patients on PD. Approximately 17% of patients initially placed on HD and 27% of
patients initially placed on PD switched therapy at least once.
Cox regression was employed, stratified by dialysis modality, and adjusting for
age, gender, race, underlying renal diagnosis, region and various comorbid illnesses
(cerebrovascular accident, cardiovascular disease, chronic obstructive pulmonary dis-
ease (COPD), malignancy, peripheral vascular disease, other illnesses). Through
stratification, a distinct baseline mortality hazard is allowed for HD and PD, which
allows the effect of dialysis method to be non-proportional and assumes no specific
functional form for the non-proportionality. The resulting 95% pointwise and simul-
taneous confidence bands of θ1(t) in time interval [1, 90] months are given in Figure
2.1 for the ITT analysis and Figure 2.2 for the CAFS analysis. This time interval
is chosen to avoid imprecision at the beginning of follow-up due to too few deaths
occurring in the HD (reference) group, and instability at the tail of the observa-
tion time distribution. Based on the ITT analysis (treating dialysis method as fixed
at t=0), relative to HD, patients initially placed on PD had significantly increased
covariate-adjusted survival probability over the [1, 29] months interval with θ̂1(t)
ranging from a low of θ̂1(t) = 0.33 at t = 1 month, to a high of θ̂1(t) = 0.90 at t = 29
months. Survival was not significantly different for patients on PD relative to HD
during the (29, 80] months interval. Long-term survival was significantly reduced
for patients on PD after approximately 80 months with θ̂1(t) ≥ 1.17. For the CAFS
analysis (censored at first therapy switch), survival probability is higher for patients
on PD than HD for approximately the first 31 months, while the survival was not
significantly different after that point (Figure 2.2).
Comparing the ITT and CAFS analyses, as is evident from Figures 2.1-2.2, the
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ITT analysis is more precise since deaths following therapy switches are not censored.
In the short term, PD patients have significantly better survival under either analysis.
In the long run, PD survival is not significantly different from that of HD under
the CAFS analysis, but significantly lower under the ITT analysis. Supplementary
analysis revealed that both Λ̂0(t) and Λ̂1(t) were greater for the ITT than the CAFS
analysis (results not shown), implying that switching therapies (in either direction)
is associated with increased mortality hazard. Since PD patients were more likely
than HD patients to switch, it would make sense that PD would be viewed more
favorably under a CAFS (relative to ITT) approach.
2.6 Discussion
In the survival analysis of biomedical studies, non-proportional hazards are fre-
quently encountered. In this manuscript, we introduce a measure of the cumulative
treatment effects when the proportional hazards assumption does not hold across the
treatment groups. No functional form for the non-proportionality need be assumed
for our proposed estimator. In cases where hazards are in fact proportional, the pro-
posed measure reduces to the well-known hazard ratio. Simulation studies provide
evidence that the proposed estimator is approximately unbiased, while the estimated
standard errors are quite accurate. Applying our method to CORR dialysis data,
we found that long-term survival (after approximately 80 months) is significantly
reduced for patients initially placed on PD relative to HD (intent-to-treat analysis).
The difference in long-term survival is non-significant after approximately the first
31 months based on the analysis with censoring at first therapy switch.
Since dialysis modality was not randomized, our results must be interpreted with
caution. We did find that patients who were initially put on PD are healthier than
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those were put on HD in terms of comorbidity profile. This does imply that selection
bias due to unmeasured covariates may be an issue.
Various methods previously proposed to account for non-proportional hazards
in a Cox regression model have featured a time-varying regression coefficient, β(t)
(e.g., Sleeper and Harrington, 1990; Zucker and Karr, 1990; Murphy and Sen, 1991;
Sargent, 1997; Gustafson, 1998; Xu and O’Quigley, 2000; Martinussen, Scheike and
Skovgard, 2002; Scheike and Martinussen, 2004). A limitation of these and related
approaches is that the estimator represents an instantaneous metric and, in the
presence of non-proportional hazards, investigators are usually more interested in the
cumulative than the instantaneous effect. The quantity
∫ t
0
β(s)ds is often proposed to
estimate the cumulative effect. Despite its utility, a drawback of this approach is that
the integral cannot generally be connected back to the treatment-specific cumulative




β(s)ds = 0 generally will not imply S0(t) = S1(t) and usually




β(s)ds = b0 implies equal survival. Our proposed approach does not consider
the estimation of the instantaneous treatment effect, but proposes a direct measure
for the cumulative effect. In terms of the survival function, equal survival at time t
among the treatments being compared is implied by θj(t) = 1. In the situation where
researchers are interested in whether and when two survival curves cross, our method
is preferable. In addition, an advantage of the method proposed in this manuscript
is that it is computationally straightforward.
We derived the variance for the proposed estimator using the modern theory
of empirical processes, instead of the Martingale Central Limit Theorem (Fleming
and Harrington, 1991). Although the asymptotic results are easier to derive using
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Martingale theory, the sandwich-type asymptotic variance derived through empiri-
cal processes should be more robust to model misspecification, such as missing co-
variate information, covariate measurement error and mis-modeling of adjustment
covariates. In addition, the proposed variance could be easily extended to recur-
rent event setting, wherein the event of interest can be experienced more than once
per subject. When proportionality does not hold across the treatment groups, we
could fit a stratified version of the proportional means model (Lin et al., 2000),
E[Nij(t)] ≡ µij(t) = µ0j(t) exp{β
T
0 Zi}, for i = 1, · · · , n, where µ0j(t) is unspecified
baseline mean function for the jth treatment group. Among the methods available
for recurrent event data (e.g., see Cai and Schaubel, 2004), the marginal means ap-
proach of Lin et al. (2000) would be considered a suitable method for comparing
treatments. To compare treatment group j(> 0) to the reference group (j=0), one
could use the ratio of the mean numbers of events, θ∗j (t) = µ0j(t)/µ00(t) as a metric
for the cumulative treatment effect. The estimate for θ∗j (t) has same expression as
in the univariate survival case, but with Nij(t) representing the number of events
in (0, t] instead of a time-dependent observed death indicator. The asymptotic re-
sults would be essentially the same after adding the condition that Nij(t) < η < ∞.
The asymptotic variance of θ̂∗j (t) could be consistently estimated by that based on
Theorem 2 of the current report, upon replacing Λ0j(t) with µ0j(t).
In this chapter, our focus has been on the treatment effect. When the proportional
hazard assumption does not hold for an adjustment covariate, traditional methods
can be applied to remedy the non-proportionality; e.g., interactions with t.
Note that our proposed estimation procedure considers the case where the adjust-
ment covariate vector is assumed to be time-independent. This is not a limitation for
at least two important reasons. First, the assumption of time-independent adjust-
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ment covariates matches the reality in most cases, such as the application in Section
5. Second, in settings where Zi(t) 6= Zi, it would be preferable to use Zi = Zi(0)
(i.e., the baseline covariate value) anyway, due to interpretation issues. For ease of
illustration, suppose treatment is fixed at t = 0 but that the adjustment covariate,
Zi(t), varies over time; Zi(0), as opposed to Zi(t), is included as an adjustment co-
variate. Consider two cases: (i) Zi(t) is uncorrelated with treatment (ii) Zi(t) is
correlated with treatment. In case (i), θ̂1(t) would be estimating the same quantity
whether or not the adjustment covariate was coded as time-dependent, rendering the
use of Zi(t) (in place of Zi) unnecessary. In case (ii), θ̂1(t) could be substantially
biased towards 1 if the adjustment covariate was coded as time-dependent in the
model. If Zi(t) is correlated with treatment after adjusting for Zi(0), it is much
more likely that treatment is at least in part causing the variation in Zi(t), directly
or indirectly, than the other way around; i.e., considering the temporality. Take
the dialysis data in Section 5 as an example. We adjust for comorbid conditions,
which are coded at time t=0. In the CORR database, serial comorbidity data are
not available. But, even if they were, we would prefer to compare PD and HD only
adjusting for time 0 comorbidity. It is quite plausible that, in addition to affecting
the mortality hazard, dialysis method has other intermediate consequences relating
to (for example) hospitalizations and the incidence of comorbid conditions. Suppose
that PD (relative to HD) reduces mortality and decreases the incidence of cardiovas-
cular disease (CVD), and that CVD onset increases mortality risk. If we adjust for
time-dependent CVD, then we end up, essentially, comparing PD and HD patients of
similar prognosis, therefore underestimating the magnitude of the difference between
therapies with respect to mortality. In understanding this phenomenon, it helps to
think of time-dependent covariates as intermediate end-points. It is well known in
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survival analysis that adjusting for components of the causal pathway is inappropri-
ate; as is made clear in survival-related causal inference approaches; e.g., Robins and
Greenland (1994), Hernan, Brumback and Robins (2001), who proposed marginal
structural models for use when adjustment covariates are time-dependent. If time-
dependent comorbidity data were available, they could perhaps be incorporated by
a marginal structural-type extension of the methods proposed in this article.
If proportionality holds across the treatment groups, such that the model λij(t) =
λ0(t) exp{ρj + β
T
0 Zi} applies, then our proposed measure θj(t) equals exp{ρj} for
t ∈ [tL, tU ]. To test for proportionality, we have H0 : θj(t) = exp{ρj} and H1 : θj(t) 6=





, we can obtain that
n1/2 [exp(ρ̂j) − exp(ρj)] = n
−1/2
∑n
i=1 Ψij + op(1), where Ψij is an mean 0 variate.
Therefore, n1/2
{




i=1 [ξij(t, β) − Ψij ]
is asymptotically a Gaussian process with mean 0. The quantity n−1/2Ri [ξij(t, β) − Ψij]
would have the same distribution as n1/2[θ̂j(t) − exp(ρ̂j)] under H0, where Ri, i =
1, · · · , n, follows a standard normal distribution. Therefore, using techniques sim-




∣∣∣ under H0. A test for the constancy of the treatment
effect could then be based on this statistic.
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2.7 Tables and Figures
n γ0 γ1 α0 α1 C% θ1(t0.75) BIAS ASE ESD CP
500 1.4 1.2 0.4 0.35 0% 0.739 0.002 0.084 0.087 0.94
200 0.008 0.132 0.139 0.94
100 0.020 0.188 0.206 0.92
500 1.4 1.2 0.4 0.35 10% 0.741 0.006 0.084 0.084 0.95
200 0.014 0.134 0.132 0.96
100 0.030 0.191 0.199 0.94
500 1.4 1.2 0.1 0.07 0% 0.468 0.005 0.055 0.058 0.93
200 -0.001 0.085 0.088 0.93
100 0.011 0.121 0.125 0.93
500 1.4 1.2 0.1 0.07 54% 0.536 0.001 0.081 0.077 0.95
200 0.014 0.130 0.133 0.94
100 0.017 0.184 0.188 0.93
500 1 1.5 0.5 0.3 0% 0.926 0.004 0.104 0.109 0.94
200 0.012 0.165 0.170 0.93
100 0.029 0.235 0.238 0.94
500 1 1.5 0.5 0.3 10% 0.912 0.007 0.103 0.103 0.95
200 0.019 0.165 0.170 0.94
100 0.015 0.230 0.238 0.92
500 1 1.5 0.2 0.1 0% 1.123 0.014 0.128 0.131 0.95
200 0.023 0.203 0.214 0.94
100 0.042 0.289 0.308 0.94
500 1 1.5 0.2 0.1 40% 0.933 0.006 0.121 0.118 0.95
200 0.014 0.192 0.197 0.94
100 0.016 0.272 0.287 0.93
500 1.5 1.5 0.4 0.2 0% 0.500 0.003 0.058 0.058 0.95
200 0.004 0.091 0.093 0.95
100 0.018 0.131 0.138 0.94
500 1.5 1.5 0.4 0.2 10% 0.500 0.003 0.058 0.056 0.96
200 0.002 0.091 0.091 0.94
100 0.018 0.131 0.138 0.94
500 1.5 1.5 0.1 0.05 0% 0.500 0.002 0.058 0.057 0.95
200 0.010 0.092 0.092 0.94
100 0.016 0.130 0.134 0.93
500 1.5 1.5 0.1 0.05 52% 0.500 0.009 0.075 0.076 0.94
200 0.014 0.120 0.121 0.94
100 0.014 0.169 0.177 0.93
Table 2.1: Simulation results: Examination of bias and accuracy of estimated standard error
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γ0 γ1 α0 α1 C% θ1(t0.75) BIAS ASE ESD CP
1.4 1.2 0.4 0.35 0% 0.739 0.042 0.266 0.294 0.91
10% 0.741 0.034 0.265 0.292 0.92
1.4 1.2 0.1 0.07 0% 0.468 0.023 0.169 0.182 0.91
54% 0.536 0.048 0.269 0.300 0.90
1.0 1.5 0.5 0.3 0% 0.926 0.048 0.331 0.347 0.92
10% 0.912 0.068 0.334 0.381 0.91
θ̂1 1.0 1.5 0.2 0.1 0% 1.123 0.086 0.415 0.480 0.92
40% 0.933 0.083 0.403 0.461 0.90
1.5 1.5 0.4 0.2 0% 0.500 0.028 0.182 0.205 0.92
10% 0.500 0.031 0.183 0.202 0.92
1.5 1.5 0.1 0.05 0% 0.500 0.027 0.182 0.199 0.91
52% 0.500 0.038 0.244 0.271 0.90
γ0 γ1 α0 α1 C% log θ1(t0.75) BIAS ASE ESD CP
1.4 1.2 0.4 0.35 0% -0.303 -0.010 0.342 0.364 0.94
10% -0.300 -0.020 0.342 0.365 0.94
1.4 1.2 0.1 0.07 0% -0.759 -0.021 0.347 0.376 0.93
54% -0.624 -0.034 0.470 0.502 0.95
1.0 1.5 0.5 0.3 0% -0.077 -0.009 0.339 0.352 0.94
10% -0.092 0.001 0.341 0.381 0.93
log(θ̂1) 1.0 1.5 0.2 0.1 0% 0.117 0.003 0.342 0.373 0.92
40% -0.069 -0.008 0.398 0.436 0.94
1.5 1.5 0.4 0.2 0% -0.693 -0.018 0.348 0.387 0.93
10% -0.693 -0.009 0.347 0.379 0.93
1.5 1.5 0.1 0.05 0% -0.693 -0.016 0.347 0.377 0.92
52% -0.693 -0.042 0.461 0.488 0.94
Table 2.2: Simulation results: Examination of bias and accuracy of estimated standard error for
small sample size (n=50)
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γ0 γ1 α0 α1 C% t θ1(t) BIAS ASE ESD CP
1 1.5 0.5 0.3 0% t0.10 0.287 0.013 0.104 0.110 0.93
t0.25 0.449 0.003 0.089 0.091 0.94
t0.50 0.665 0.006 0.089 0.087 0.95
t0.75 0.926 0.004 0.104 0.109 0.94
t0.90 1.130 0.016 0.137 0.141 0.94
1 1.5 0.5 0.3 10% t0.10 0.306 0.005 0.100 0.102 0.94
t0.25 0.469 0.004 0.089 0.086 0.95
t0.50 0.671 0.004 0.089 0.091 0.94
t0.75 0.912 0.007 0.103 0.103 0.95
t0.90 1.060 0.003 0.126 0.133 0.94
1 1.5 0.2 0.1 0% t0.10 0.387 0.011 0.123 0.129 0.94
t0.25 0.610 0.011 0.110 0.119 0.94
t0.50 0.869 0.009 0.111 0.114 0.94
t0.75 1.123 0.014 0.128 0.131 0.95
t0.90 1.440 0.004 0.178 0.182 0.94
1 1.5 0.2 0.1 40% t0.10 0.397 0.005 0.120 0.123 0.92
t0.25 0.594 0.003 0.109 0.114 0.94
t0.50 0.819 0.005 0.110 0.106 0.95
t0.75 0.933 0.006 0.121 0.118 0.95
t0.90 1.040 0.020 0.153 0.156 0.94
Note: tq = q
′th percentile of observation time distribution, C%=percent censored, ASE=average
asymptotic standard error, ESD=empirical standard deviation, CP=coverage probability.
Table 2.3: Simulation results: Examination of bias and accuracy of estimated standard error at
different time points (n=500)
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Figure 2.1: Analysis of dialysis data: Estimator and 95% pointwise confidence intervals and simul-
taneous confidence bands for the ratio of cumulative hazard functions (PD/HD), θ1(t),
for the ITT analysis.
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Figure 2.2: Analysis of dialysis data: Estimator and 95% pointwise confidence intervals and simul-
taneous confidence bands for the ratio of cumulative hazard functions (PD/HD), θ1(t),
for the CAFS analysis.
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2.8 Appendix
Proof of Theorem 1
One can write:



























Λ̂00(t, β̂) − Λ00(t)
}
+ o(n−1/2).
For j = 0, · · · , m, set φ̂j(t) = Λ̂0j(t, β̂) − Λ0j(t) = φ̂j1(t) + φ̂j2(t), where:
φ̂j1(t) = Λ̂0j(t, β̂) − Λ̂0j(t, β0)
φ̂j2(t) = Λ̂0j(t, β0) − Λ0j(t).






































(β̂ − β0) + o(n
−1/2).
















Using the facts that Nij(s), S
(1)
j (s, β) are bounded, and S
(0)
j (s, β) is bounded away
from 0 as n → ∞, ĥj(t, β0) is bounded for sufficiently large n. This, combining with
the fact that β̂
a.s.
























−→ 0 as n → ∞






Combining (2.11), (2.13) and (2.15), give the consistency of φ̂j(t) for j = 0, · · · , m
and t ∈ [0, τ ]. This, combining with the fact that Λ̂0j(t, β̂)
a.s.
→ Λ0j(t) (Anderson and
Gill, 1982) concludes the proof of the uniform consistency of θ̂j(t).
Proof of Theorem 2
We now consider the convergence of n1/2[θ̂j(t) − θj(t)]. One can write
n1/2φ̂j1(t) = n
1/2ĥj(t, β0)











Conditions (a) to (f) and the SLLN give ĥj(t, β0)
a.s.
−→ hj(t, β0) as n → ∞, where


















−→ zj(t, β) as n → ∞, Ψ̂i(β) converges to Ψi(β) defined as in (2.8).
By a Taylor series expansion, one can write












j (s, β) − Zj(s, β)
⊗2]dNij(s).
As n → ∞, Ω̂(β) converges to Ω(β), a positive definite matrix defined as in (2.4).
These results yield






With respect to φ̂j2(t), using the fact that S
(0)
j (s, β0)




as n → ∞ and various results from empirical processes (Bilias, Gu and Ying, 1997;




























−1dMij(s, β0) + op(1).(2.17)
Combining (2.16) and (2.17), one can write n1/2φ̂j(t) = n
−1/2
∑n
i=1 Φij(t, β0) + op(1)










with ξij(t, β0) defined as in (2.5), which is a sum of n independent and identically
distributed random variables. By the Central Limit Theorem, n1/2[θ̂j(t) − θj(t)]
converges to a mean-zero normal distribution. To prove the weak convergence, we
show tightness of n1/2[θ̂j(t) − θj(t)], which can be demonstrated by the manage-
ability of ξij(t, β0) for i = 1, · · · , n. Since Φij(t, β0) and Φi0(t, β0) are differ-
ences of functions monotone in t, Φij(t, β0) and Φi0(t, β0) are manageable. Hence,
ξij(t, β0) = Λ00(t)
−1Φij(t, β0) − Λ00(t)
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CHAPTER III
Weighted Estimation Of Treatment Effects In The Presence
Of Non-Proportional Hazards
ABSTRACT: In medical studies featuring survival time data, it is very common
that treatment-specific hazards are non-proportional. A frequently used method of
dealing with non-proportional hazards is to apply a Cox model that assumes that
the treatment effect is a specific function of time. However, it is often difficult to
choose the correct parametric form for the treatment effect. Even if the correct form
is chosen, investigators are usually more interested in the cumulative effect than
the instantaneous effect in the presence of non-proportional hazards. We propose
methods for estimating the cumulative treatment effect when proportional hazards
does not hold. Three measures are proposed: ratio of cumulative hazards, rela-
tive risk and difference in restricted mean lifetime. No functional form need be
assumed for the effects of treatment or the adjustment covariates. The proposed
measures are estimated through non-parametric procedures after using inverse prob-
ability of treatment weighting (IPTW) to balance the treatment-specific covariate
distributions. Asymptotic properties of the proposed estimators are derived, with
finite-sample properties assessed in simulation studies. The proposed methods are
applied to end stage renal disease (ESRD) data.
KEY WORDS: Cumulative hazard; Inverse weighting; Nonparametric estimator;
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Relative risk; Restricted mean lifetime; Survival analysis
3.1 Introduction
In survival analysis, the most frequently used method is the Cox proportional
hazards model (Cox 1972, 1975). When the proportional hazards assumption does
not hold, the effect of covariates is often assumed to follow a pre-specified function
of time. However, it is usually hard to assess whether the chosen functional form
is correct. Moreover, when proportional hazards does not hold, investigators are
usually more interested in the cumulative effect than the instantaneous effect. For
example, in the presence of a treatment effect which changes direction over time,
clinicians are often more interested in knowing when the survival probabilities (as
opposed to hazard functions) are same for the two treatment groups.
As an alternative to the Cox non-proportional hazards model, one could compare
survival or cumulative hazard curves using Nelson-Aalen (Nelson, 1972; Aalen, 1978)
or Kaplan-Meier (Kaplan and Meier, 1958) estimators. In fact, several methods have
been proposed to estimate cumulative treatment effects. Doksum and Song (1989)
constructed confidence intervals and simultaneous confidence bands for a relative
change function, expressed in terms of cumulative hazard functions. Parzen, Wei
and Ying (1997) compared two survival functions and constructed confidence bands
based on simulation techniques. McKeague and Zhao (2002) proposed the ratio of
survival functions and constructed simultaneous confidence bands using empirical
likelihood. The above listed methods are designed for nonparametric settings and
do not adjust for potential confounders. It is well known that these estimators
may lead to biased results when the treatments are not randomly assigned, as is
the case in observational studies. We propose methods to estimate the cumulative
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treatment effect by comparing the cumulative hazard, risk of death and restricted
mean lifetime between treatment groups. We apply inverse probability of treatment
weighting (IPTW) to adjust for potential confounders. If a subject has a higher
(lower) probability of being in a certain treatment group, then the subject is given
a lower (higher) weight.
This work is motivated by the continued desire to compare survival of end-stage
renal disease patients on two dialysis methods: hemodialysis (HD) and peritoneal
dialysis (PD). Peritoneal dialysis is less expensive, but newer and less established.
Previous studies comparing HD and PD mortality have produced conflicting results.
For example, using non-proportional hazards models assuming a piece-wise constant
hazard ratio, Fenton et al. (1997) found that hazard ratios (PD/HD) significantly
decreased early in the follow-up period, but that the effect changed direction later
on, while Bloembergen et al. (1995) reached very different conclusions based on U.S.
national data. Wei and Schaubel (2008) compared the cumulative hazard of death
for patients treated by PD to those treated by HD using a stratified Cox model. The
authors assumed that the effect of each adjustment covariate was constant over time.
Applying our methods to Canadian Organ Replacement Register (CORR) data, we
now seek to compare PD and HD without assuming proportional hazards for either
the treatment or the adjustment covariates. The average cumulative hazard, risk of
death, and restricted mean lifetime are compared between PD and HD.
Inverse probability of treatment weighting (IPTW; Hernan, Brumback & Robins,
2000; Robins, Hernan & Brumback, 2000) has been used to estimate the causal effect
of time-dependent exposure and adjust for time-dependent confounders. Hernan et
al. (2000) assumed proportional hazards for the exposure and adjustment covariate
effects. In the case that there exist time-dependent confounders which are affected by
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previous exposure and predict the subsequent exposure, the authors argued that the
standard Cox partial likelihood estimator is a unbiased estimate of the association
between the exposure and failure time, but is a biased estimate of the causal effect
if only baseline covariates are adjusted in the Cox model. To estimate the causal ef-
fect, an inverse weight involving each subject’s probability of receiving the exposure
actually received at time t given previous exposure and covariates history (includ-
ing the time-dependent confounders which are affected by exposure) was applied to
each subject. The model adjusted for time-constant but not the time-dependent
confounders. Our proposed methods differ from those of Hernan et al. (2000) in at
least three important ways. First, we estimate the marginal treatment effect, i.e., the
effect of assigning treatment to a patient from an intent-to-treat perspective. Second,
we do not assume proportionality with respect to the treatment or the adjustment
covariates. Third, we estimate the cumulative effect of treatment.
Current methods for estimating the cumulative effect in the context of censored
data usually focus on the survival or cumulative hazard function. However, mean
lifetime is often the more relevant quantity. For example, patients usually ask “How
long will I live?”, not “What is my 5-year survival probability?”. This is true in many
areas of medicine and is particularly true for organ failure patients. For example, in
the U.S., the liver allocation system is currently being restructured such that patients
will be ranked on the waiting list by difference in 5-year restricted mean lifetime. We
propose estimating the cumulative treatment effect through IPTW-based estimators
for the cumulative hazard, risk of death and restricted mean lifetime. Essentially,
treatment-specific pseudo populations with the same confounder distribution are
created by applying IPTW. Since the weighted treatment groups have the same
adjustment covariate distribution, confounding is eliminated and estimation then
41
proceeds nonparametrically. Therefore, functional forms for neither the treatment
nor the adjustment covariate effects need to be specified.
The remainder of this Chapter is organized as follows. In the next section, we
describe our proposed methods. Asymptotic properties of the proposed estimators
are developed in Section 3.3. We evaluate the performance of our estimators for finite
samples in Section 3.4. In Section 3.5, we apply our proposed method to compare
survival on hemodialysis and peritoneal dialysis using data from a national organ
failure registry. We provide some discussion of the proposed methods in Section 3.6.
3.2 Proposed methods
Suppose that a total of n subjects are included in the study. Let Ti be the
event time and Ci be the censoring time for subject i. Let Xi = min{Ti, Ci} and
δi = I(Ti ≤ Ci) represent the observation time and event indicattor, respectively,
where I(A) is an indicator function taking the value 1 when condition A holds and
0 otherwise. The at-risk indicator is denoted by Yi(t) = I(Xi ≥ t) and the observed
death counting processes is defined as Ni(t) = δiI(Xi ≤ t). Let J+1 be the number of
treatment groups (numbered j = 0, 1, . . . , J), where the first group (j=0) represents
a reference category to which the remaining treatment groups are compared. Let
Gi denote the treatment group for subject i and set Gij = I(Gi = j). We let




T assumed to be independent and identically distributed, where Zi is
a p×1 vector of covariates. We assume that Ci and Ti are independent given Gi and
that there are no unmeasured confounders.
Our objective is compare the average survival that would result if treatment j was
applied to the entire population to that if treatment 0 was applied to the entire pop-
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ulation. The survival probability at time t if all subjects were assigned to treatment
j is denoted by Sj(t) = EZi[S(t|Gi = j,Zi)], where S(t|Gi = j,Zi) is the survival
probability given treatment j and the adjustment covariates. The expectation is with
respect to the marginal distribution of Zi, such that same averaging is done across
all J + 1 groups. Note that the quantity
∫ t
0
Sj(s)ds equals the average restricted
mean lifetime considered by Chen & Tsiatis (2001). The averaging we propose is
done through inverse weighting, while Chen & Tsiatis (2001) explicitly averaged the
fitted values from a treatment stratified proportional hazards model.











T for j = 1, · · · , J , with 01×(j−1)(p+1) a 1 by (j −
1)(p + 1) matrix with elements 0. The estimate for β0, β̂ is obtained by maximum






Xij [Gij − pij(β)] .(3.1)
Let Λj(t) = − log{Sj(t)} denote the cumulative hazard if treatment j was assigned
to the entire population. The probability that the event occurs by time t is denoted by
Fj(t) = 1−Sj(t) and the restricted mean lifetime through (0, t] is denoted by ej(t) =
∫ t
0
Sj(u)du. To compare treatment j to the reference treatment, three measures are
proposed:











(iii) Difference in restricted mean lifetime
∆j(t) = ej(t) − e0(t).(3.4)
The measure φj(t) relates to the hazard ratio usually used when proportional haz-
ards holds. The measure RRj(t) is a process version of relative risk, a quantity used
regularly in epidemiologic studies. The quantity ∆j(t) measures the area between
the treatment j and treatment 0 survival curves.
Measures (3.2), (3.3) and (3.4) can be estimated using the inverse probability of









∆̂j(t, β̂) = êj(t, β̂) − ê0(t, β̂),


















j (s, β) = n
−1
∑n
i=1 Yij(s)wij(β) and wij(β̂) = Gij/pij(β̂) is the estimator
for wij(β0) = Gij/pij(β0). The quantity Λ̂j(t, β̂) is a weighted version of the Nelson-
Aalen estimator. Measures (3.2) and (3.3) are considered in a time interval [tL, tU ],
and (3.4) is considered in a time interval (0, tU ], where tL is chosen to avoid instances
in which Λ̂0(t, β̂) = 0 and tU is chosen to avoid the instability in tail of the observation
time distribution.
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After applying IPTW, J+1 pseudo populations are created, where the distribution
of Zi is balanced among the treatment groups and is same as that of the entire
population. For example, (3.4) compares the restricted mean lifetime through (0, t],
if treatment j was assigned to the entire population to that if the reference treatment
was assigned to the entire population.
3.3 Asymptotic properties
To derive the large-sample properties of estimators proposed in preceding section,
we assume the following regularity conditions for i = 1, · · · , n and j = 0, · · · , J .
(a) Zik have bounded total variation; i.e., |Zik| < κ for k = 1, · · · , p, where κ is a
constant and Zik is the kth component of Zi.
(b) Λj(τ) < ∞ where τ is a pre-specified time point satisfying Pr(Yij(τ) = 1) > 0.
(c) Continuity of r
(0)
j (t, β), where r
(0)
j (t, β) is the limiting value of R
(0)
j (t, β) with
r
(0)
j (t, β) bounded away from 0 for t ∈ [0, τ ] for β in an open set.













(e) Pr(Gij = 1) > 0.
Asymptotic properties of the estimators are summarized by the following three
theorems:
THEOREM 1. Under conditions (a) to (e), φ̂j(t, β̂) converges almost surely and
uniformly to φj(t), and n
1/2[φ̂j(t, β̂) − φj(t)] converges asymptotically to a zero-































































The consistency of φ̂j(t, β̂) is proved by the Strong Law of Large Numbers (SLLN)
and continuous mapping theorem as well as the consistency of β̂ and Λ̂j(t, β̂). The
estimator Λ̂j(t, β̂) is proved to be consistent by using the SLLN and the fact that β̂ is
consistent. The quantities n1/2[Λ̂j(t, β̂)−Λj(t)] and n
1/2[Λ̂0(t, β̂)−Λ0(t)] can each be
written as sums of independent and identically distributed variates. The convergence
of n1/2[φ̂j(t, β̂) − φj(t)] involves writing the quantity as functions of n
1/2[Λ̂j(t, β̂) −
Λj(t)] and n
1/2[Λ̂0(t, β̂)−Λ0(t)], then applying the Central Limit theorem and results
from empirical process (Bilias, Gu and Ying, 1997; Pollard, 1990). The quantity in
ξφij(t, β0) is consistently estimated by its empirical counterparts.
THEOREM 2. Under conditions (a) to (e), R̂Rj(t, β̂) converges almost surely and
uniformly to RRj(t), and n
1/2[R̂Rj(t, β̂)−RRj(t)] converges asymptotically to a zero-













with Φij(t, β) defined as in Theorem 1.
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In the next theorem, we consider the asymptotic behavior of our restricted mean
lifetime difference estimator.
THEOREM 3. Under conditions (a) to (e), ∆̂j(t, β̂) converges almost surely and
uniformly to ∆j(t), and n
1/2[∆̂j(t, β̂) − ∆j(t)], converges asymptotically to a zero-




ij (t, β0)], for
j = 1, · · · , J and t ∈ (0, τU ], where







The proof for Theorem 2 and Theorem 3 proceeds much like that of Theorem 1.
3.4 Simulation study
We evaluated the finite sample properties of the proposed estimator through a
series of simulation studies. A covariate Zi1 was generated from a Uniform (0,1)
distribution and a covariate Zi2 was generated as a binary variable (0 or 1) with
Pr(Zi2 = 1) = 0.5. We set up two treatments, with the treatment indicator, Gi,
generated from a Bernoulli distribution with parameter pi1(β) = exp(β0 + β1Zi1 +
β2Zi2)/{1 + exp(β0 + β1Zi1 + β2Zi2)}. We chose β0 = 0.1, β1 = 0.2 and β2 = −0.2.
We generated the death times from a Weibull model with hazard function
λij(t) = λi(t|Gi = j, Zi1, Zi2) = αjγjt
γj−1 exp{η1Zi1 + η2Zi2} for j = 0, 1.
Censoring times were generated from a Uniform (2.5, 5) distribution. Various values
of γj were used to make the hazard ratio constant or vary through time. Censoring
percentages ranged from 18% to 36%. Values of η1 = ±0.5 and η2 = ±0.5 were
employed in the Cox model. We chose sample sizes n = 200 and n = 100. A total
of 1000 simulations were used for each setting. For the first two measures, φj(t) and
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RRj(t), we employed the log transformation, such that confidence intervals would
always be in a valid range. Each of the three estimators were evaluated at time
points t = 1, t = 2 and t = 3.
The proposed estimators generally perform well (Table 3.2 and Table 3.3). The
empirical mean of our estimators is approximately equal to the true value. The aver-
age asymptotic standard errors (ASE) are generally close to the empirical standard
deviations (ESD), while the coverage probabilities (CP) are close to the nominal
value of 0.95 (Table 3.4).
We also checked the impact of misspecification of the treatment assignment prob-
ability model on estimates of our measures. The treatment indicator, Gi, was gen-
erated from a Bernoulli distribution with
Pr(Gi = 1|Zi1, Zi2) =
exp(0.2 − 0.5 × Zi1 + Zi2 + Zi1 × Zi2)
1 + exp(0.2 − 0.5 × Zi1 + Zi2 + Zi1 × Zi2)
,
where Zi1 was generated from a Uniform (0,1) distribution and Zi2 was generated
from a Bernoulli (0.4) distribution. Death times, Ti, were generated from a Cox
model with hazard function
λij(t) = λ0j(t) exp{0.5 × Zi1 + 0.5 × Zi2},
where λ00(t) = 0.2 and λ01(t) = 0.25. We evaluated the performance of our estima-
tors when some covariate terms were omitted or misspecified in the logistic model.
When some covariates are not included in the logistic model, the estimates of our
measures are biased, depending on the degree of misspecification (Table 3.5). For
example, when Zi2 has a strong effect on treatment assignment, the estimates are
very biased when Zi2 is excluded from the fitted logistic model. Results for a model
containing only Zi1 were comparable to the intercept-only model.
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3.5 Analysis of dialysis data
We applied our proposed methods to compare the survival of end stage renal
disease (ESRD) patients by dialysis therapy. Data were obtained from the Cana-
dian Organ Replacement Register (CORR) which is a nation-wide and population-
based organ failure registry. Our analysis included patients who were either put on
hemodialysis (HD) or peritonital dialysis (PD) at the time of renal replacement ther-
apy initiation. We carried out an intent-to-treat analysis which classified patients
based on the type of dialysis received at the initiation of renal replacement therapy.
Hemodialysis served as the reference category (j=0).
This study included n=23,254 ESRD patients aged 18 and above who initiated
HD or PD between 1990 and 1998. Patients began follow-up at the date of dialy-
sis initiation and were followed until the earliest of death, loss to follow-up, kidney
transplantation or the end of the observation period (December 31, 1998). There
were 17,766 patients initially placed on HD, and approximately 38% of them died,
while 36% of patients on PD (5,488) were observed to die. Potential confounders
included in the data set are patient’s age, gender, race, underlying renal diagno-
sis, region and various comorbid illnesses (cerebrovascular accident, cardiovascular
disease, chronic obstructive pulmonary disease (COPD), malignancy, peripheral vas-
cular disease, other illnesses). The probability of initiating dialysis on PD (HD) was
calculated using a logistic model adjusting for the above covariates, with interaction
terms included when significant. Interaction terms are selected by a backward elim-
ination algorithm which started with a model that contained all main effects and all
pair-wise interaction terms, forcing the main effects to be included.
We computed our proposed estimators over the (0, 96] month interval. Figure 3.1
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shows that the cumulative hazard of death is significantly lower comparing PD to
HD during the first 32 months with point estimate ranges from 0.38 to 0.94, while
after month 45, the cumulative hazard of death is significantly higher for PD relative
to HD with the cumulative hazard ratio ranges from 1.06 to 1.22. The mortality risk
ratio comparing PD to HD ranges from 0.38 to 0.95 for the first 32 months, with
the risk of death is significantly lower for PD relative to HD (Figure 3.2). The risk
of death for PD is significantly higher after month 45 with the risk ratio ranging
from 1.04 to 1.08. The restricted mean lifetime (in months) for the first 84 months
is greater for PD compared to HD, although the difference is only significant in the
(0,66] months time interval (Figure 3.3). The maximum difference is 1.4 months,
statistically significant, although not likely of clinical importance.
3.6 Discussion
In this Chapter, we propose methods to estimate the cumulative treatment effect.
The proposed methods would be most useful in observational studies due to the
potential for bias in the absence of accounting for confounders. Our methods do
not require that the proportional hazards assumption hold for either the treatments
or the adjustment covariates. The proposed measures compare patient cumulative
hazard of death, risk of death and restricted mean lifetime if the treatment was
assigned to the entire population to that if the reference treatment was assigned
to the entire population. Simulation studies show that the proposed estimators are
approximately unbiased and that the estimated standard errors are quite accurate.
Our proposed methods do not require specifying the functional form of the effects
of treatment or adjustment covariates. However, unlike a typical Cox model, we
do need to model the treatment assignment probability and the consistency of our
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proposed estimators is based on the correct estimate for this probability. Although we
essentially trade one model for another, a binary (multinominal) outcome is typically
easier to model than a hazard function due to the absence of the time dimension.
Various methods in the existing literature are related to those we propose. For
example, a method proposed by Anstrom and Tsiatis (2001) can be used to compare
treatment-specific survival funcations at a fixed time point, but was not designed to
measure the treatment effect as a process over time. Xie and Liu (2005) developed
an inverse probability of treatment weighted Kaplan-Meier estimator to estimate
the survival function. This estimator reduced the bias of unweighted nonparametric
Kaplan-Meier estimator when confounders for treatment exist. A weighted log rank
statistic was proposed to test for the difference between the two survival curves. The
authors did not propose a measure to estimate the treatment effect along with time
while our proposed measures give a view of the time-dependent treatment effect.
Moreover, we compared restricted mean lifetime which interests many researchers.
Chen & Tsiatis (2001) compared the restricted mean lifetime between two treat-
ment groups. A Cox model was fitted for each treatment group such that the authors
assumed that the effects of adjustment covariates follow proportional hazards. The
survival function for each group was estimated by explicitly averaging over all sub-
jects in the sample. The treatment-specific survival function (and hence, restricted
mean lifetime) estimators we propose converge to the same values as the estimators
proposed by Chen & Tsiatis (2001) under their specified model. One advantage of
our estimators is that those of Chen & Tsiatis (2001) require explicitly averaging over
all observed covariate patterns which would be taxing computationally, particulary
for large data sets. Another advantage of our estimators is that we need not specify a
functional form for the effects of adjustment covariates. Conversely, Chen & Tsiatis
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(2001) do not need to assume that the censoring is conditionally independent of the
adjustment covariates.
In this chapter, we constructed confidence intervals of proposed measures. If
we want to look at the measures as a process over time, confidence bands can be
constructed as in Wei and Schaubel (2008). However, confidence intervals are often
preferred over confidence bands, since researchers are usually interested in the cumu-
lative effect at some specific time point or set of time points. For example, surgeons
want to know the restricted mean lifetime at 1, 3 and 5 years. In this case, point-wise
confidence intervals are more appropriate.
Applying our methods to the CORR dialysis data using an intent-to-treat anal-
ysis, we found that cumulative hazard and risk of death are significantly lower for
PD relative to HD for the first 32 months while the opposite was found after ap-
proximately 45 months from dialysis initiation. We found that the restricted mean
life is significant longer comparing PD to HD based on the first 66 months while the
difference is non-significant after that. We assumed that there is no selection bias
due to unmeasured covariates which may be an issue since the assignment of dialysis
may depend on patient characteristics for which no data are available to CORR. As
such, our results must be interpreted with some caution.
Our proposed methods assume that censoring does not depend on confounders for
treatment, although sub-analysis revealed that the censoring hazard does in fact de-
pend on certain adjustment covariates. However, φ̂1(t) (ratio of cumulative hazards)
was similar to what we found in Chapter 2 which does not require that censoring time
is independent of the covariates. This gives evidence that, even if the Ci and Zi in-
dependence assumption is violated, the results were not very biased. As a sensitivity
analysis to further address the dependent censoring issue, we applied an inverse cen-
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soring weight (Robins and Rotnitzky, 1992; Robins, 1993) and IPTW concurrently
to our estimators. The modified weight is given by
wij(t) =
Yij(t)
Pr(Gi = j|Zi)Pr(Ci > t|Gi = j,Zi)
.
The point estimates based on the modified estimators were quite similar to what
we reported in last section. We develop a generalization of this method in the next
chapter.
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3.7 Tables and Figures
Setting α0 α1 γ0 γ1 η1 η2
I 0.35 0.25 1 1 0.5 0.5
II 0.35 0.25 1 1 -0.5 0.5
III 0.35 0.25 1 1 0.5 -0.5
IV 0.2 0.35 1.2 1 0.5 0.5
V 0.2 0.35 1.2 1 -0.5 0.5
VI 0.2 0.35 1.2 1 0.5 -0.5
Table 3.1: Simulation study: Parameter settings
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t=1 t=2 t=3
Setting log φ1(t) BIAS log φ1(t) BIAS log φ1(t) BIAS
I -0.329 0.001 -0.323 0.004 -0.317 0.009
II -0.332 -0.005 -0.328 -0.011 -0.324 -0.007
III -0.332 -0.003 -0.328 -0.001 -0.324 0.003
log φ̂1(t) IV 0.549 0.007 0.404 0.001 0.320 -0.002
V 0.553 0.003 0.411 -0.007 0.327 -0.009
VI 0.553 0.023 0.411 0.010 0.327 0.003
Setting log RR1(t) BIAS log RR1(t) BIAS log RR1(t) BIAS
I -0.254 0.001 -0.190 0.001 -0.142 0.003
II -0.284 -0.005 -0.239 -0.008 -0.201 -0.005
III -0.284 -0.004 -0.239 -0.002 -0.201 0.002
log R̂R1(t) IV 0.434 0.008 0.243 0.002 0.143 -0.001
V 0.481 0.004 0.303 -0.005 0.203 -0.005
VI 0.481 0.021 0.303 0.009 0.203 0.003
Setting ∆1(t) BIAS ∆1(t) BIAS ∆1(t) BIAS
I 0.060 -0.001 0.173 -0.003 0.287 -0.005
II 0.041 -0.001 0.136 0.001 0.250 0.002
III 0.041 -0.001 0.136 -0.001 0.250 -0.002
∆̂1(t) IV -0.106 0.001 -0.263 0.001 -0.392 0.003
V -0.072 0.001 -0.201 0.005 -0.327 0.009
VI -0.072 -0.001 -0.201 -0.003 -0.327 -0.004
Table 3.2: Simulation results: Evaluation of bias (n=200)
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t=1 t=2 t=3
Setting log φ1(t) BIAS log φ1(t) BIAS log φ1(t) BIAS
I -0.329 -0.023 -0.323 0.001 -0.317 0.002
II -0.332 0.026 -0.328 0.004 -0.324 0.005
III -0.332 -0.007 -0.328 -0.001 -0.324 -0.008
log φ̂1(t) IV 0.549 0.021 0.404 0.005 0.320 0.014
V 0.553 0.024 0.411 0.008 0.327 -0.001
VI 0.553 0.020 0.411 0.003 0.327 0.006
Setting log RR1(t) BIAS log RR1(t) BIAS log RR1(t) BIAS
I -0.254 -0.020 -0.190 -0.001 -0.142 -0.001
II -0.284 0.022 -0.239 0.003 -0.201 0.003
III -0.284 -0.007 -0.239 -0.001 -0.201 -0.006
log R̂R1(t) IV 0.434 0.022 0.243 0.007 0.143 0.011
V 0.481 0.025 0.303 0.009 0.203 0.003
VI 0.481 0.021 0.303 0.005 0.203 0.006
Setting ∆1(t) BIAS ∆1(t) BIAS ∆1(t) BIAS
I 0.060 0.002 0.173 0.002 0.287 -0.002
II 0.041 -0.004 0.136 -0.009 0.250 -0.013
III 0.041 -0.001 0.136 -0.003 0.250 -0.005
∆̂1(t) IV -0.106 0.001 -0.263 0.001 -0.392 -0.001
V -0.072 0.001 -0.201 0.002 -0.327 0.004
VI -0.072 0.002 -0.201 0.004 -0.327 0.005
Table 3.3: Simulation results: Evaluation of bias (n=100)
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Setting log φ1(t) BIAS ASE ESD CP
I -0.323 0.004 0.182 0.187 0.94
II -0.328 -0.011 0.211 0.213 0.95
III -0.328 -0.001 0.211 0.211 0.96
log φ̂1(t) IV 0.405 0.001 0.186 0.191 0.94
V 0.411 -0.007 0.216 0.224 0.94
VI 0.411 0.010 0.217 0.219 0.95
Setting log RR1(t) BIAS ASE ESD CP
I -0.190 0.001 0.109 0.111 0.95
II -0.239 -0.008 0.155 0.157 0.95
III -0.239 -0.002 0.155 0.155 0.96
log R̂R1(t) IV 0.244 0.002 0.114 0.118 0.94
V 0.303 -0.005 0.162 0.168 0.94
VI 0.303 0.009 0.162 0.164 0.95
Setting ∆1(t) BIAS ASE ESD CP
I 0.173 -0.003 0.098 0.101 0.95
II 0.136 0.001 0.092 0.092 0.95
III 0.136 -0.001 0.093 0.094 0.95
∆̂1(t) IV -0.264 0.002 0.095 0.099 0.95
V -0.201 0.005 0.088 0.089 0.94
VI -0.201 -0.003 0.088 0.092 0.95
Table 3.4: Simulation results: Accuracy of standard error estimator (t=2, n=200)
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Covariates in logistic model log φ1(t) BIAS ASE ESD CP




, Z2, Z2 × Z
†
1
0.216 0.004 0.223 0.233 0.94
Z1, Z2 0.216 0.009 0.225 0.229 0.95
Z2 0.216 0.001 0.225 0.228 0.95
Z1 0.216 0.166 0.213 0.217 0.88
None 0.216 0.159 0.214 0.217 0.88
Covariates in logistic model log RR1(t) BIAS ASE ESD CP




, Z2, Z2 × Z
†
1
0.149 0.006 0.158 0.161 0.94
Z1, Z2 0.149 0.009 0.158 0.161 0.95
Z2 0.149 0.003 0.158 0.160 0.95
Z1 0.149 0.117 0.151 0.154 0.90
None 0.149 0.113 0.151 0.153 0.89
Covariates in logistic model ∆1(t) BIAS ASE ESD CP




, Z2, Z2 × Z
†
1
-0.099 0.002 0.105 0.111 0.93
Z1, Z2 -0.099 -0.001 0.107 0.109 0.94
Z2 -0.099 0.003 0.107 0.109 0.94
Z1 -0.099 -0.072 0.097 0.101 0.86




= 1, if Z1 < 0.5; Z
†
1
= 0, if Z1 ≥ 0.5
Table 3.5: Simulation results: Effect of model misspecification (t=2, n=200)
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Figure 3.1: Analysis of dialysis data: Estimator and 95% pointwise confidence intervals for the ratio
of cumulative hazard functions (PD/HD), φ1(t).
59
Figure 3.2: Analysis of dialysis data: Estimator and 95% pointwise confidence intervals for the risk
ratio (PD/HD), RR1(t).
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Figure 3.3: Analysis of dialysis data: Estimator and 95% pointwise confidence intervals for the
difference in restricted mean lifetime (PD-HD), ∆1(t).
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3.8 Appendix
Proof of Theorem 1
Consistency:
The strong consistency of φ̂j(t, β̂), j = 1, · · · , J , can be proved by first proving the













Using the fact that wij(β̂)
a.s.
−→ wij(β0) as n → ∞, and the Strong Law of Large
Numbers (SLLN), one can obtain that n−1
∑n
i=1 Yij(s)ŵij(β̂) converges almost surely
to
E [Yij(s)wij(β0)]
= E {E [Yij(s)wij(β0)|Zi]}
= E
{




Pr−1(Gi = j|Zi)Pr(Ti > s|Gi = j,Zi)Pr(Ci > s|Gi = j,Zi)Pr(Gi = j|Zi)
]
= Pr(Ci > s|Gi = j)E [Pr(Ti > s|Gi = j,Zi)]
= Pr(Ci > s|Gi = j)E [S(s|Gi = j,Zi)]
= Pr(Ci > s|Gi = j)Sj(s)
Using similar techniques, one can obtain that n−1
∑n
i=1 wij(β̂)dNij(s) converges
almost surely to Pr(Ci > s|Gi = j)dFj(s) as n → ∞. The above listed results give
Λ̂j(t, β̂)
a.s.
−→ Λj(t) for j = 0, · · · , J . Therefore, φ̂j(t, β̂) converges to φj(t) almost






















Λ̂j(t, β̂) − Λj(t)
]









Λ̂j(t, β0) − Λj(t)
]
.















































By Taylor Series expansions, α̂j1(t) can be written as
α̂j1(t) = ĥj(t)










































By the Strong Law of Large Numbers (SLLN), R
(0)
j (s, β̂) and R
(0)
j (s, β0) converge to
r
(0)
j (s, β0), and n
−1
∑n
i=1 aij(β0)Yij(s) converges to E[aij(β0)Yij(s)]. Therefore, by
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By a Taylor expansion, one can obtain that
n−1/2U(β0) = Ω̂(β0)n














By using the SLLN, Ω̂(β0) converges to Ω(β0) defined as in (3.5). Since U(β0) can
be written as in (3.1), we obtain that






Xij [Gij − pij(β0)] + op(1)(3.9)
Using results (3.8), (3.9) and the fact that ĥj(t)
a.s.










Xij [Gij − pij(β0)] + op(1).(3.10)































Based on (3.10) and (3.11), one can obtain that
n1/2
[



































Λ̂0(t, β̂) − Λ0(t)
]
+ op(1).
Therefore, one can write
n1/2
[




























Since E[Φij(t, β0)] = 0 for j = 0, · · · , J , n
1/2
[
φ̂j(t, β̂) − φj(t)
]
is a scaled sum
of n independent and identically distributed mean 0 random variates and there-
fore converges to a mean 0 Normal distribution, for fixed t. Furthermore, since
[




φ̂j(t, β̂) − φj(t)
]
converges to a zero mean Gaussian
process with covariance function E[ξφij(s, β0)ξ
φ




















Proof of Theorem 2
Since Λ̂j(t, β̂) converges almost surely to Λj(t), by the continuous mapping theorem,
R̂Rj(t, β̂) converges almost surely to RRj(t). With respect to asymptotic normality,
one can write
























By Functional Delta Method,
n1/2
[





















Λ̂0(t, β̂) − Λ0(t)
]
+ op(1).
Above listed results give













Λ̂0(t, β̂) − Λ0(t)
]
+ op(1),
which is a sum of mean 0 variates, using the fact that n1/2[Λ̂j(t, β̂) − Λj(t)] =
n−1/2
∑n
i=1 Φij(t, β0) + op(1) for j = 0, · · · , J , shown in the proof of Theorem 1.
Multivariate Central Limit Theorem and results from empirical process can be used,
as in the proof of Theorem 1, to demonstrate that n1/2
[
R̂Rj(t, β̂) − RRj(t)
]
con-
verges asymptotically to a mean 0 Gaussian process.
Proof of Theorem 3
Using the fact that Λ̂j(t, β̂) converges almost surely to Λj(t) and the continuous
mapping theorem, we obtain that ∆̂j(t, β̂) converges almost surely to ∆j(t). With
respect to the asymptotic normality, one can write
n1/2
[






















Ŝ0(s, β̂) − S0(s)
]
ds.
























−Sj(s)Φij(s) + S0(s)Φi0(s)ds + op(1),
which is a sum of n independent and identically distributed mean 0 random variables.
Similar to the proof of Theorem 1, one can obtain that n1/2[∆̂j(β̂, t)−∆j(t)] converges
to a mean 0 Gaussian process with covariance function E[ξ∆ij (s, β0)ξ
∆




Aalen O.O. (1978). Nonparametric inference for a family of counting processes. The
Annals of Statistics 6, 701-726.
Anstrom K.J., Tsiatis, A.A. (2001). Utilizing propensity scores to estimate causal
treatment effects with censored time-lagged data. Biometrics 57, 1207-1218.
Bilias, Y., Gu, M. and Ying, Z. (1997). Towards a general asymptotic theory for the
Cox model with staggered entry. The Annals of Statistics 25, 662-682.
Bloembergen, W.E., Port, F.K., Mauger, E.A., and Wolfe, R.A. (1995). A compari-
son of mortality between patients treated with hemodialysis and peritoneal dialysis.
Journal of American Society of Nephrology 6, 177-183.
Chen, P. and Tsiatis A.A. (2001). Causal inference on the difference of the restricted
mean lifetime between two groups. Biometrics 57 1030-1038.
Cox, D.R. (1972). Regression models and life tables. Journal of the Royal Statistical
Society, Series B 34, 187-202.
Cox, D.R. (1975). Partial likelihood. Biometrika 62, 269-276.
Dabrowska, D.M., Doksum, K.A. and Song, J. (1989). Graphical comparison of
cumulative hazards for two populations. Biometrika 76, 763-773.
Fenton, S.S., Schaubel, D.E., Desmeules, M., Morrison, H.I. Mao, Y., Copleston, P.,
Jeffery, J.R. and Kjellstrand, C.M. (1997). Hemodialysis versus peritoneal dialysis:
A comparison of adjusted mortality rates. American Journal of Kidney Diseases 30,
334-342.
68
Fleming, T.R. and Harrington, D.P. (1991). Counting Processes and Survival Anal-
ysis. New York: Wiley.
Hernan, M.A., Brumback, B. and Robins, J.M. (2000). Marginal structural models
to estimate the causal effect of zidovudine on the survival of HIV-positive men.
Epidemiology 11, 561-570.
Hernan, M.A., Brumback, B. and Robins, J.M. (2001). Marginal structural models
to estimate the joint causal effect of nonrandomized treatments. Journal of the
American Statistical Association 96, 440-448.
Kaplan, E.L. and Meier, P. (1958). Nonparametric estimation from incomplete ob-
servations. Journal of the American Statistical Association 53, 457-481.
Lin, D.Y., Fleming, T.R. and Wei, L.J. (1994). Confidence bands for survival curves
under the proportional hazards model. Biometrika 81, 73-81.
McKeague, I.W. and Zhao, Y. (2002). Simultaneous confidence bands for ratios
of survival functions via empirical likelihood. Statistics & Probability Letters 60,
405-415.
Nelson, W.B. (1972). Theory and applications of hazard plotting for censored failure
data. Technometrics 14, 945-965.
Parzen, M.I., Wei, L.J. and Ying, Z. (1997). Simultaneous confidence intervals for
the difference of the two survival functions. Scandinavian Journal of Statistics 24,
309-314.
Pollard, D. (1990). Empirical processes: Theory and Applications. Institute of
Mathematical, Hayward, CA and Alexandria, VA.
69
Robins, J.M. and Rotnitzky, A. (1992). Recovery of information and adjustment for
dependent censoring using surrogate markers. AIDS Epidemiology – Methodological
Issues, Jewell N, Dietz K, Farewell V (eds). Birkhauser: Boston, MA, 297-331.
Robins, J.M. (1993). Information recovery and bias adjustment in proportional haz-
ards regression analysis of randomized trials using surrogate markers. Proceedings
of the Biopharmaceutical Section, American Statistical Association, 24-33.
Robins J.M., Hernan, M.A. and Brumback, B. (2000). Marginal Structrural Models
and Causal Inference in Epidemiology. Epidemiology 11, 550-560.
Wei, G. and Schaubel D.E. (2008). Estimating cumulative treatment effects in the
presence of non-proportional hazards. Biometrics 64, 724 - 732.
Xie, J. and Liu, C. (2005). Adjusted Kaplan-Meier estimator and log-rank test with
inverse probability of treatment weighting for survival data. Statistics in Medicine
24, 3089-3110.
CHAPTER IV
Estimating Cumulative Treatment Effects In The Presence
Of Non-Proportional Hazards And Dependent Censoring
ABSTRACT: In medical studies of time to event data, non-proportional hazards
and dependent censoring are very common issues when estimating the treatment
effect. A traditional method for dealing with time-dependent treatment effects is
to model the time-dependence parametrically. Limitations of this approach include
the difficulty to verify the correctness of the specified functional form and the fact
that, in the presence of a treatment effect that varies over time, investigators are
usually interested in the cumulative as opposed to instantaneous treatment effect.
In many applications, censoring time is not independent of event time. Therefore, we
propose methods for estimating the cumulative treatment effect in the presence of
non-proportional hazards and dependent censoring. As in Chapter 3, the three pro-
posed measures include the ratio of cumulative hazards, relative risk and difference in
restricted mean lifetime. For each measure, we propose a double-inverse-weighted es-
timator, constructed by first using inverse probability of treatment weighting (IPTW)
to balance the treatment-specific covariate distributions, then using inverse probabil-
ity of censoring weighting (IPCW) to handle the dependent censoring. The proposed
estimators are consistent and aymptotically normal. We study their finite-sample
properties through simulation. The proposed methods are used to compare kidney
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wait list mortality by race.
KEY WORDS: Cumulative hazard; Dependent censoring; Inverse weighting; Rela-
tive Risk; Restricted mean lifetime; Survival analysis; Treatment effect.
4.1 Introduction
In clinical and epidemiologic studies of survival data, it is very common that
the treatment effect is not constant over time. In the presence of non-proportional
hazards, the Cox (1972) model is often modified such that the treatment effect is
assumed to vary as a specified function of time. However, the functional form chosen
may not be correct. Moreover, researchers are usually more interested in the cu-
mulative treatment effect in settings where the treatment effect is time-dependent.
Without specifying the functional form of the treatment effect, one can compare
survival or cumulative hazard curves using the Nelson-Aalen (Nelson, 1972; Aalen,
1978) estimator or Kaplan-Meier (Kaplan and Meier, 1958) estimator. These esti-
mators may lead to biased results when confounders for treatment exist, as is often
the case in observational studies. When censoring time depends on factors predictive
of the event, the event and censoring time are correlated through these factors. If
these prognostic factors are time-dependent and if they are not only risk factors for
the event but also affected by treatment, standard methods of covariate adjustment
(such as Cox regression) may produce biased treatment effects. If baseline values in-
stead of time-dependent factors are adjusted, standard methods are still invalid since
the event and censoring times will be dependent through their mutual correlation
with the time-dependent factors.
The investigation which motivated our proposed research involves comparing wait-
list survival for patients with end-stage renal disease. The effect of race (Caucasian
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vs African American) on survival is of interest and may vary over time. A patient’s
hospitalization history is a predictor of wait-list mortality and also affects trans-
plantation probability, since patients with more hospitalizations are less likely to
receive a kidney transplant. Although a patient’s death may be observed following
kidney transplantation, receipt of a transplant does censor their wait-list mortality.
Therefore, the mortality and censoring will be correlated unless the model adjusts
for hospitalization history. However, one would not want to adjust for hospitaliza-
tion history, since doing so may result in the marginal effect of race being under or
over estimated. Therefore, we need to handle dependent censoring in this analysis.
In addition, there are some time constant covariates, such as age and diagnosis, for
which adjustment is necessary.
Current methods usually focus on the survival or cumulative hazard function when
estimating cumulative treatment effects in the presence of censored data. However,
mean lifetime is often relevant since patients usually want to know how long they
will live. Chen & Tsiatis (2001) compared restricted mean lifetime between two
treatment groups using treatment-specific Cox proportional hazard models. The
survival function for each group was estimated by averaging over all subjects in the
sample. Their proposed model requires that proportionality holds for the adjustment
covariates.
Without specifying the functional form for the effects of adjustment covariates,
inverse probability of treatment weighting (IPTW) can be applied to balance the dis-
tribution of confounders among the treatment groups. Hernan, Brumback & Robins
(2000, 2001) and Robins, Hernan & Brumback (2000) used marginal structural mod-
els to estimate the causal effect of a time-dependent exposure. Inverse weighting
was applied to adjust for time-dependent confounders that are affected by previous
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treatment. In the context of survival analysis, the authors assumed Cox propor-
tional hazard models; i.e., the effect of treatment is assumed to be constant. With
respect to the related nonparametric methods, Xie and Liu (2005) developed an ad-
justed Kaplan-Meier curve using inverse weighting to handle potential confounders,
assuming that the event time and censoring time are independent.
Inverse probability of censoring weighting (IPCW) has been applied in many ap-
plications to overcome dependent censoring. This method is originally proposed by
Robins and Rotnitzky (1992). A Cox proportional hazard model is assumed for
the event time, while an inverse probability of censoring weight is applied in the
estimating equation for the effect parameters. This weight is the inverse of the sur-
vival function for censoring, which is estimated by non-parametric or semiparametric
Kaplan-Meier estimators from a Cox model. Robins and Finkelstein (2000) applied
IPCW to handle dependent censoring in an AIDS clinical trial. The IPCW method
has been applied in various other settings (Matsuyama & Yamaguchi, 2008; Yoshida,
Matsuyama & Ohashi, 2007).
We propose three cumulative treatment effect measures: ratio of cumulative haz-
ards, relative risk, and difference in restricted mean lifetime. The proposed esti-
mators are computed by double inverse weighting, wherein inverse probability of
treatment weighting (IPTW; Hernan, Brumback & Robins, 2000, 2001; Robins, Her-
nan & Brumback, 2000) is used to balance the treatment-specific baseline adjustment
covariate distributions and IPCW (Robins and Rotnitzky 1992; Robins 1993) is con-
currently applied to handle the dependent censoring due to time-varying factors.
After applying the double inverse weight to the observed data, estimation of the cu-
mulative treatment effects proceeds nonparametrically, negating the need to specify
functional forms for the effect of either the treatment or the adjustment covariates.
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The remainder of this chapter is organized as follows. We describe our proposed
methods in the next section. In Section 4.3, we derive the asymptotic properties of
our proposed estimators. We evaluate the performance of our estimators for finite
samples in Section 4.4. In Section 4.5, we apply the methods to kidney wait list
data. Discussion is provided in Section 4.6.
4.2 Proposed methods
Suppose that n subjects are included in the data set. Let Di be the event time and
Ci be the censoring time for subject i. Let Xi = min{Di, Ci} and δi = I(Di ≤ Ci)
where I(A) is an indicator function taking the value 1 when condition A holds and 0
otherwise. The observed event counting processes is defined as NDi (t) = δiI(Xi ≤ t)
and the observed censoring counting processes is defined as NCi (t) = (1−δi)I(Xi ≤ t).
The risk indicator is denoted by Yi(t) = I(Xi ≥ t). Let j (j = 0, 1, . . . , J) be the
index for treatment group, with group j = 0 representing a reference category to
which the remaining treatment groups are compared. Let Gi denote the treatment
group for subject i and set Gij = I(Gi = j). Correspondingly, we set Yij(t) =
Yi(t)Gij, dN
D
ij (t) = dN
D
i (t)Gij and dN
C
ij (t) = dN
C
i (t)Gij . The observed data consist




Z̃i(t) = {Zi(s); s ∈ [0, t]} and Zi(t) is a p× 1 vector of covariates which may contain
some time-dependent elements. We let Zi(0) denote the covariate values at baseline.
In the case where Zi(t) not only affects the event time but also affects censoring,
event and censoring are dependent unless the effect of Zi(t) on the event is modeled
explicitly. However, we usually would prefer adjust for Zi(0), instead of Zi(t) when
Zi(t) is affected by treatment. It is of interest to compare the average survival
that would result if treatment j was assigned to the entire population to that if
75
reference treatment was assigned to the entire population. The average survival
function if treatment j was assigned to is given by Sj(t) = E[S(t|Gi = j,Zi(0))].
The expectation is with respect to the marginal distribution of Zi(0), such that the
same averaging is done across all J + 1 treatment groups.
To compare the cumulative effect of treatment j to the reference treatment, three





where Λj(t) = − log{Sj(t)} is the cumulative hazard at time t. The measure φj(t)
is equal to the hazard ratio we usually use when proportional hazard holds. The





where Fj(t) = 1−Sj(t) is the probability of death by time t. The RRj(t) is a process
version of relative risk, a quantity which is frequently estimated in epidemiologic
studies. The third proposed measure is the difference in restricted mean lifetime,




Sj(u)du is the area under the survival curve (restricted mean life-
time) through (0, t]. The ∆j(t) measure equals the area between the survival curves
that would result if treatment j versus treatment 0 was assigned to all subjects in
the population.
Let Xij = [01×(j−1)(p+1), 1,Z
T
i (0), 01×(J−j)(p+1)]
T where 01×(j−1)(p+1) is a 1 by (j −
1)(p + 1) matrix with elements 0, for j = 1, · · · , J . We assume that treatment








where pij(β0) = Pr(Gi = j|Zi(0)). The model could be extended to include interac-
tion terms. The maximum likelihood estimator of β0, denoted by β̂, is the root of






Xij [Gij − pij(β)] .(4.4)
Since it is preferred to adjust for Zi(0) instead of Zi(t), the event and censoring
processes are dependent through their mutual association with Zi(t) for t > 0. We
apply an inverse probability of censoring weight to handle the dependent censoring.
We assume that Ci follows a Cox model with hazard function defined as:







where ZCi (t) contains terms representing Gi and Zi(t). The inverse censoring weight
at time t is denoted by wCi (t, θ0) = Yi(t) exp{Λ
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quantity wCi (t, θ0) is estimated by ŵ
C
i (t, θ̂) = Yi(t) exp{Λ̂
C
i (t, θ̂)}, where

























⊗d exp{θTZCi (t)} for d = 0, 1, 2 with a
⊗0 = 1,
a⊗1 = a and a⊗2 = aaT for a vector a. The quantity ΛC0 (t, θ̂) is the Nelson-Aalen
estimator for ΛC0 (t). The parameter θ0 is estimated through partial likelihood (Cox,






















Note that if proportional hazards does not hold for treatment effect, a stratified Cox
model can be applied to obtain treatment-specific survival functions for the censoring
distribution.
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Λ̂0(t, β̂, ŵC(t, θ̂))
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F̂0(t, β̂, ŵC(t, θ̂))
,
where F̂j(t, β, ŵ
C(t, θ)) = 1 − Ŝj(t, β, ŵ
C(t, θ)). The estimator for difference in re-
stricted mean lifetime, ∆j(t), is given by
∆̂j(t) = êj(t, β̂, ŵ
C(t, θ̂)) − ê0(t, β̂, ŵ
C(t, θ̂)),






The measures φj(t) and RRj(t) are considered on a time interval [tL, tU ], and
∆j(t) is considered in a time interval [0, tU ], where tL is chosen to avoid division by
0 and tU is chosen to avoid the well known instability in the tail of the observation
time distribution.
The IPTW weight, wGij(β0), is used for balancing the covariate distribution among
the treatment groups. After applying wGij(β0) to our estimators, J + 1 pseudo-
populations are created with treatment-specific Zi(0) distribution equals to that
of the entire population. For example, for the restricted mean lifetime ej(t) =
∫ t
0
E[S(s|Gi = j,Zi(0))]ds, the expectation is with respect to the marginal distri-
bution of Zi(0), such that same averaging is done across all J + 1 treatment groups.
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The IPCW weight, wCi (t, θ0), is applied to handle the dependent censoring. After
applying the proposed double inverse weighting, the weighted versions of each of the
proposed measures converges to the same true values listed in Chapter 3.
4.3 Asymptotic properties
To derive the large-sample properties of estimators proposed in last section, we
assume the following regularity conditions for i = 1, · · · , n and j = 0, · · · , J .
(a) Λj(τ) < ∞ and Λ
C
i (τ) < ∞, where τ is a pre-specified time point.
(b) Zik(t) are bounded for t ∈ [0, τ ]; i.e., |Zik(t)| < κ for k = 1, · · · , p, where κ is a
constant and Zik(t) is the kth component of Zi(t).
(c) Continuity of the following functions:
r
(1)





C (t, θ), r
(2)








C (t, θ) is the limiting value of R
(d)
C (t, θ) for d = 0, 1, 2, with r
(0)
C (t, θ) bounded
away from 0 for t ∈ [0, τ ] and θ in an open set.
(d) For (βT , θT )T in an open set, the quantity r
(0)
j (t, β, θ) is continuous and bounded
away from 0 in [0, τ ], where r
(0)
j (t, β, θ) is the limiting value of R
(0)
j (t, β, w
C(t, θ)).



























C (t, θ) − z
C(t, θ)⊗2,




C (t, θ) is the limiting value of Z
C
(t, θ).
(f) Pr(Gij = 1) > 0.
We summarize the asymptotic properties of the proposed estimators in the fol-
lowing theorems.
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THEOREM 1. Under conditions (a) to (f), φ̂j(t) converges almost surely and uni-
formly to φj(t) for t ∈ [tL, tU ], and n
1/2[φ̂j(t) − φj(t)] converges asymptotically to a
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1
Λ0(t)
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j (s, β, θ)
dMDij (s)
dMDij (s) = dN
D
ij (s) − Yij(s)dΛj(s)
THEOREM 2. Under conditions (a) to (f), R̂Rj(t) converges almost surely
and uniformly to RRj(t) for t ∈ [tL, tU ], and n
1/2[R̂Rj(t, θ̂) − RRj(t)] converges




ij(t, β0, θ0)], where
ξRij(t, β, θ) =
Sj(t)
F0(t)




with Φij(t, β, θ) defined as in Theorem 1.
THEOREM 3. Under conditions (a)-(f), ∆̂j(t) converges almost surely and uni-
formly to ∆j(t) for t ∈ [0, tU ], and n
1/2[∆̂j(t)−∆j(t)], converges asymptotically to a
zero-mean Gaussian process with covariance function σ∆j (s, t) = E[ξ
∆
ij (s, β0, θ0)ξ
∆
ij (t, β0, θ0)],
where
ξ∆ij (t, β, θ) =
∫ t
0
{S0(s)Φi0(s, β, θ) − Sj(s)Φij(s, β, θ)} ds,(4.9)
with Φij(t, β, θ) defined as in Theorem 1.
The consistency of φ̂j(t), R̂Rj(t) and ∆̂j(t) is proved by the consistency of β̂, θ̂,
the continuous mapping theorem, and the Uniform Strong Law of Large Numbers
(SLLN). The proof of asymptotic normality involves decomposing
[
Λ̂j(t, β̂, ŵ
C(t, θ̂)) − Λj(t)
]




























C(t, θ̂)) − Λj(t)
]
then can be written as sum of indepen-
dent and identically distributed mean 0 variates. Using the Functional Delta Method,
we can write each of n1/2[φ̂j(t) − φj(t)], n
1/2[R̂Rj(t) − RRj(t)] and n
1/2[∆̂j(t) −
∆j(t)] as functions of n
1/2[Λ̂j(t, β̂, ŵ




1/2[∆̂j(t)−∆j(t)] can be written as sum of independent
and identically distributed mean 0 variates. The Multivariate Central Limit Theo-
rem and various results from the theory of empirical processes (Pollard, 1990; Bilias,
Gu &Ying, 1997) are applied in the proof. The covariance function can be consis-
tently estimated by replacing all limiting values with their empirical counterparts.
For large data set, variance computation can be computationally intense, in which
case the bootstrap is a useful alternative.
4.4 Simulation study
We evaluated the finite sample properties of the proposed estimators through a
series of simulation studies. Due to the computation of derived asymptotic variance,
we evaluated the bootstrap variances. For each of the n subjects, a covariate Zi1
was generated as a binary variable with values 0 or 1 and Pr(Zi1 = 1) = 0.5. The
treatment indicator, Gi, was generated from a Bernoulli distribution with parameter
pi1(β) = exp(β0 + β1Zi1)/ [1 + exp(β0 + β1Zi1)]. We chose β0 = log(1/3) and β1 =
log(9) such that Pr(Zi1 = 1|Gi = 1) = 0.75 and Pr(Zi1 = 1|Gi = 0) = 0.25.
When Gi = 1, we generated a variable Zi2 as piece-wise constant with probabilities
P (Zi2 = k) = P (Zi2 = k + 1) = 0.5 across time interval (k, k + 1], for k = 0, · · · , 4.
When Gi = 0, Zi2 was generated as a binary variable (0 or 1) with Pr(Zi2 = 1) = 0.5.
Event times were generated from a Cox model with hazard function
λi(t) = λ0(t) exp{η1Gi + η2Zi1 + η3Zi2(t)},
while censoring times were generated from a Cox model with hazard function




Various values of (η1, η2, η3), and θ were employed for the Cox models. For each
set of parameters, several percentages of censoring were investigated by varying the
baseline death and censoring hazards. Censoring times were truncated at t = 5.
Sample sizes of n = 500 and n = 200 were examined, and a total of 1000 simula-
tions were used for each simulation setting. For the first two measures, we employed
the log transform to ensure that the confidence interval bounds were in a valid range.
To assess the finite-sample performance of our proposed method, the bias of each
of the three estimators was evaluated at time points t = 1, t = 2 and t = 3. The
bootstrap standard errors were evaluated at t = 2 with sample size n = 200, and 100
bootstrap resamples per simulation.
For n = 200, our estimators appear to be approximately unbiased in general
(Table 4.1). The bias is reduced when sample size increases to n = 500 (Table 4.2).
The average bootstrap standard errors (ASE) are genearlly close to the empirical
standard deviations (ESD) for sample size n = 200 (Table 4.3) and, correspondingly,
the empirical coverage probabilities (CP) are fairly close to the nominal value of 0.95.
4.5 Data analysis
We applied the proposed methods to analyze wait-list survival for patients with
end-stage renal disease, where the effect of race (Caucasian vs. African American)
was of interest. Data were obtained from the Scientific Registry of Transplant Re-
cipients (SRTR) and collected by the Organ Procurement and Transplant Network
(OPTN). Hospitalization data were obtained from the Center for Medicare Sciences
(CMS). Only patients whose primary payer was Medicare were included in the anal-
ysis. The data included n=7110 Caucasian and African American patients who were
placed on kidney transplant waiting list in calender year 2000. Among the 2975
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African Americans, 27% died and 45% received a kidney transplant. Among the
4135 Caucasians, 27% died and 54% got transplanted. Patients were followed from
the time of placement on the kidney transplant waiting list to the earliest of death,
transplantation, loss to follow-up or end of study (Dec 31, 2005).
It has been reported that African Americans have lower kidney wait list mortality
rate than Caucasians. However, Caucasians also have a higher kidney transplant rate
than African Americans. Unlike liver, lung and heart transplantation, poor patient
health is a contra-indication for kidney transplantation. Although donor kidneys are
not specially directed towards healthier patients, it is generally felt that patients in
poorer health are less likely to receive a kidney transplant. It is quite possible that the
healthiest patients are transplanted off the wait list at a greater rate for Caucasians
than for African Americans. Therefore, we suspect that dependent censoring exists
of kidney wait list mortality via kidney transplantation. We use time-dependent
hospitalization history as a surrogate for patient health. Note that hospitalization
history is inappropriate as an adjustment covariate for patient wait list survival.
Patients with a greater number of previous hospitalizations have a greater mortality
hazard and hospital admissions can be viewed as intermediate end points along the
path from wait listing to death. Previous comparisons of wait list mortality by race
did not adjust for dependent censoring. Moreover, most previous comparisons of
Caucasians and African Americans assumed that effect of race is constant over time.
Logistic regression was used to model the probability that a patient is Caucasian
given age, gender, diagnosis (diabetes, hypertension, Glaucoma, polycystic kidney
disease and other), body mass index and chronic obstructive lung disease (yes or
no). A stratified Cox model (stratified by race) was fitted to estimate the inverse
probability censoring weight adjusting for the covariates listed above, as well as
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time-dependent number of hospitalizations. The transplant hazard is significantly
decreased by 8% for each additional hospitalization (Table 4.4). The IPTW weight
ranged from 1.04 to 21.39 and the IPCW weight ranged from 1.04 to 33.07.
Due to the size of the data set, standard errors of the estimators were based on the
m of n bootstrap to reduce computation time. The idea is to sample with replacement
m subjects from all n subjects in the sample. The standard error estimator is then
the bootstrap standard error multiplied by
√
m/n. We sampled 1000 subjects from
the 7110 subjects for each bootstrap resample and 5000 bootstrap samples were
drawn.
We evaluated the race effect over the [0,70] month interval. Within approximately
one month after wait listing, Caucasians have significantly lower cumulative hazard
of death than African Americans (Figure 4.1). The cumulative hazard is lower at the
very beginning of wait-listing, while it is significantly higher comparing Caucasians to
African Americans after approximately 11 months with ratio of cumulative hazards
ranged from φ̂1(t) = 1.18 to φ̂1(t) = 1.47. The pattern of the estimated relative risk is
similar as ratio of cumulative hazards (Figure 4.2). Figure 4.3 shows that Caucasians
have shorter restricted mean lifetime than African Americans based on the first 8
months after wait-listing. The difference in restricted mean lifetime is significant after
18 months of wait-listing, with the estimated difference ranging from ∆̂1(t) = −0.17
months to ∆̂1(t) = −3.39 months comparing Caucasians to African Americans.
We compared the results above to those without applying inverse censoring weight.
The double inverse weighting estimates for ratio of cumulative hazards and relative
risk are lower than those without applying IPCW, especially after 22 months of wait-
listing. When dependent censoring is ignored, the estimated difference of restricted
mean lifetime is smaller than the estimates based on double inverse weighting, espe-
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cially towards the end of follow-up period.
4.6 Discussion
In this chapter, we proposed measures to estimate the cumulative treatment ef-
fect when the proportional hazards assumption does not hold. The proposed esti-
mators adjust for discrepancies in treatment-specific baseline covariate distribution
and overcome dependent censoring due to time-dependent covariates by applying
double inverse weighting. Simulation studies show that the proposed estimators are
approximately unbiased and the estimated standard errors are accurate.
Applying our methods to kidney wait list survival data, we found that the effect
of race (Caucasian vs. African American) is time dependent. The cumulative hazard
and risk of death are significantly higher for Caucasians relative to African Americans
11 months after wait listing, and Caucasians have significantly shorter (3.39 months
shorter) restricted mean lifetime based on the first 70 months after wait listing. The
difference in restricted mean lifetime is significant in a long term, although not of
clinical importance.
In Chapter 3, we found that misspecification of the logistic model (model for
inverse treatment weight) may bring bias to our proposed estimators. The estimates
of the proposed measures in this article also depend on the estimate for inverse
treatment weight. Therefore, misspecification of inverse treatment weight model may
bring bias to the treatment effect. The accuracy of the estimates of our proposed
measures do depend on the accuracy of the estimate of inverse probability of censoring
weight. When very few subjects are censored in the sample, it may not worthwhile
to use IPCW since the estimate for inverse probability of censoring weight may be
biased due to too small sample size for censoring. Accordingly, the estimates for our
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proposed measures may be biased in such settings.
For a very large data set, the computation of asymptotic variance of our proposed
estimators is intensive. The bootstrap method can be applied when sample size is
too large, with the m of n bootstrap method being a practical means of reducing the
computation time.
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4.7 Tables and Figures
t=1 t=2 t=3
Setting C% log φ1(t) BIAS log φ1(t) BIAS log φ1(t) BIAS
I 23% 0 0.004 0.283 0.017 0.584 0.008
40% 0 0.019 0.283 0.022 0.584 -0.007
log φ̂1(t) II 13% 0.496 0.013 0.778 0.004 1.076 0.009
33% 0.496 0.037 0.778 0.022 1.076 0.017
III 28% 0.496 0.038 0.778 0.018 1.076 0.012
46% 0.496 0.058 0.778 0.024 1.076 0.006
Setting C% log RR1(t) BIAS log RR1(t) BIAS log RR1(t) BIAS
I 23% 0 0.004 0.238 0.015 0.429 0.008
40% 0 0.019 0.238 0.019 0.429 -0.004
log R̂R1(t) II 13% 0.451 0.014 0.619 0.007 0.715 0.011
33% 0.451 0.036 0.619 0.021 0.715 0.016
III 28% 0.451 0.037 0.619 0.017 0.715 0.011
46% 0.451 0.056 0.619 0.024 0.715 0.011
Setting C% ∆1(t) BIAS ∆1(t) BIAS ∆1(t) BIAS
I 23% 0 0.001 -0.036 -0.002 -0.171 -0.002
40% 0 -0.001 -0.036 -0.004 -0.171 -0.003
∆̂1(t) II 13% -0.042 0.001 -0.197 0.005 -0.502 0.009
33% -0.042 -0.001 -0.197 -0.002 -0.502 0.001
III 28% -0.042 -0.001 -0.197 -0.002 -0.502 0.001
46% -0.042 -0.001 -0.197 -0.001 -0.502 0.005
I: η1 = 0, η2 = 0.2, η3 = 0.5, θ = 1
II: η1 = 0.5, η2 = 0.2, η3 = 0.5, θ = 1
III:η1 = 0.5, η2 = 0.2, η3 = 0.5, θ = 0.25
Table 4.1: Simulation results: Examination of bias at different time points (n=200)
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t=1 t=2 t=3
Setting C% log φ1(t) BIAS log φ1(t) BIAS log φ1(t) BIAS
I 23% 0 0.009 0.283 0.001 0.584 -0.006
40% 0 0.005 0.283 -0.001 0.584 -0.009
log φ̂1(t) II 13% 0.496 0.007 0.778 0.001 1.076 -0.011
33% 0.496 0.007 0.778 0.010 1.076 -0.011
III 28% 0.496 0.006 0.778 -0.007 1.076 -0.012
46% 0.496 0.019 0.778 0.018 1.076 0.007
Setting C% log RR1(t) BIAS log RR1(t) BIAS log RR1(t) BIAS
I 23% 0 0.009 0.238 0.001 0.429 -0.004
40% 0 0.004 0.238 0.001 0.429 -0.007
log R̂R1(t) II 13% 0.451 0.007 0.619 0.001 0.715 -0.007
33% 0.451 0.007 0.619 0.009 0.715 -0.006
III 28% 0.451 0.006 0.619 -0.004 0.715 -0.008
46% 0.451 0.018 0.619 0.015 0.715 0.005
Setting C% ∆1(t) BIAS ∆1(t) BIAS ∆1(t) BIAS
I 23% 0 -0.001 -0.036 -0.001 -0.171 0.001
40% 0 -0.001 -0.036 -0.001 -0.171 0.001
∆̂1(t) II 13% -0.042 0.001 -0.197 0.001 -0.502 0.005
33% -0.042 0.001 -0.197 -0.001 -0.502 0.003
III 28% -0.042 0.001 -0.197 0.003 -0.502 0.008
46% -0.042 -0.002 -0.197 -0.005 -0.502 -0.006
I: η1 = 0, η2 = 0.2, η3 = 0.5, θ = 1
II: η1 = 0.5, η2 = 0.2, η3 = 0.5, θ = 1
III:η1 = 0.5, η2 = 0.2, η3 = 0.5, θ = 0.25
Table 4.2: Simulation results: Examination of bias at different time points (n=500)
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Setting C% log φ1(t) BIAS ASE ESD CP
I 23% 0.283 0.017 0.331 0.317 0.96
40% 0.022 0.344 0.337 0.96
log φ̂1(t) II 13% 0.778 0.004 0.309 0.320 0.94
33% 0.022 0.323 0.332 0.95
III 28% 0.778 0.017 0.321 0.326 0.95
46% 0.024 0.347 0.356 0.95
Setting C% log RR1(t) BIAS ASE ESD CP
I 23% 0.238 0.015 0.283 0.270 0.96
40% 0.019 0.293 0.286 0.96
log R̂R1(t) II 13% 0.619 0.007 0.255 0.264 0.94
33% 0.021 0.267 0.274 0.95
III 28% 0.619 0.017 0.265 0.269 0.96
46% 0.024 0.288 0.297 0.95
Setting C% ∆1(t) BIAS ASE ESD CP
I 23% -0.036 -0.002 0.087 0.087 0.95
40% -0.004 0.089 0.090 0.94
∆̂1(t) II 13% -0.196 0.005 0.095 0.100 0.93
33% -0.002 0.096 0.099 0.93
III 28% -0.196 -0.002 0.096 0.099 0.94
46% -0.001 0.099 0.102 0.94
I: η1 = 0, η2 = 0.2, η3 = 0.5, θ = 1
II: η1 = 0.5, η2 = 0.2, η3 = 0.5, θ = 1
III:η1 = 0.5, η2 = 0.2, η3 = 0.5, θ = 0.25
Table 4.3: Simulation results: Examination of bootstrap standard errors (t=2, n=200)
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Covariate Covariate value Hazard ratio P-value
Hospitalizations 0.92 <0.001
Gender (reference=Male) 0.95 0.170
18-29 1 –
30-40 0.85 0.015
Age 40-50 0.75 <0.001
50-60 0.76 <0.001
≥60 0.66 <0.001
Lung disease (reference=No) 0.79 0.168
0-20 0.90 0.085
20-25 1 –




Glomerulo nephritis 1.11 0.120
Diagnosis Polycystic kidney disease 1.19 0.013
Hypertension 0.99 0.920
Other 1.05 0.250
Table 4.4: Analysis of wait list mortality by race: Parameter estimates for censoring model
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Figure 4.1: Analysis of wait list mortality by race: Estimator and 95% pointwise confidence intervals for
the ratio of cumulative hazard functions (Caucasian/African American), φ1(t).
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Figure 4.2: Analysis of wait list mortality by race: Estimator and 95% pointwise confidence intervals for
the risk ratio (Caucasian/African American), RR1(t).
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Figure 4.3: Analysis of wait list mortality by race: Estimator and 95% pointwise confidence intervals for
the difference in restricted mean lifetime (Caucasian-African American), ∆1(t).
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4.8 Appendix
Proof of Theorem 1
Consistency:
The strong consistency of φ̂j(t) can be proved by proving the strong consistency of
Λ̂j(t, β̂, ŵ





















Since ŵCi (s, θ̂)
a.s.




→ wGij(β0), by Strong Law of Large Num-















. Let Zi0 = Zi(0), Zis = {Zi(u); u ∈ (0, s]}, w
C
ij(s, θ0) =
Yi(s)Pr(Ci > s|Gi = j, Z̃i(s))
−1, and f(z̃i(s)) be the density function of Z̃i(s). For
ease of presentation, we assume that Z̃i(s) is continuous, in the development that



















































Pr(Ti > s|Gi = j,Zi0 = zi0)f(zi0)dzi0
= EZi0 [S(s|Gi = j,Zi0)]
≡ Sj(s).
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ij (s) converges almost
surely to E [dFj(s)]. Combining results above, and using continuity, we obtain that
Λ̂j(t, β̂, ŵ







Exploiting the continuity of φj(t) as a map of Λj(t) and Λ0(t), we obtain that φ̂j(t)
























By a Taylor Expansion, we obtain that
[
1




































For j = 0, · · · , J , one can decompose
[
Λ̂j(t, β̂, ŵ
C(t, θ̂)) − Λj(t)
]
into α̂j1(t)+α̂j2(t)+
α̂j3(t) + α̂j4(t), where
α̂j1(t) = Λ̂j(t, β̂, ŵ
C(t, θ̂)) − Λ̂j(t, β0, ŵ
C(t, θ̂))
α̂j2(t) = Λ̂j(t, β0, ŵ
C(t, θ̂)) − Λ̂j(t, β0, ŵ
C(t, θ0))
α̂j3(t) = Λ̂j(t, β0, ŵ
C(t, θ0)) − Λ̂j(t, β0, w
C(t, θ0))
α̂j4(t) = Λ̂j(t, β0, w
C(t, θ0)) − Λj(t).
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Since Rj(s, β̂, ŵ
C(s, θ̂)) and Rj(s, β0, ŵ
C(s, θ̂)) converge almost surely to r
(0)
j (s, β0, θ0)
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Therefore, we obtain that
n1/2α̂j1(t) = ĥj(t)











j (s, β0, θ0)
dNDij (s),







j (s, β0, θ0)
dNDij (s)
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converges almost surely to ΩG(β0) which is defined as in (4.6). These results along
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with (4.4) give








Xij [Gij − pij(β0)]









Xij [Gij − pij(β0)] + op(1).(4.11)
Since Rj(s, β0, ŵ
C(s, θ̂)) and Rj(s, β0, ŵ
C(s, θ0)) converge to r
(0)
j (s, β0, θ0) as n →






































j (s, β0, θ0)
dNDij (s)
By a Taylor Expansion, one can obtain that n1/2[ŵCi (s, θ̂)−ŵ
C



















By the SLLN, b̂i(s, θ0) converges to bi(s, θ0),where












Using the results above, we obtain that
n1/2α̂j2(t) = n













j (s, β0, θ0)
dNDij (s) + op(1).
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j (s, β0, θ0)
.
Using another Taylor expansion and (4.5), we obtain that









ZCi (t) − z
C(t, θ0)
}
dMCi (t) + op(1)










ZCi (t) − z
C(t, θ0)
}
dMCi (t) + op(1).
Since Rj(s, β0, ŵ
C(s, θ0)) and Rj(s, β0, w
C(s, θ0)) converge to r
(0)















j (s, β0, θ0)
dNDij (s).
Applying the Functional Delta Method,
n1/2[ŵCi (s, θ0) − w
C
i (s, θ0)] = w
C
i (s, θ0)n
1/2[Λ̂Ci (s, θ0) − Λ
C
i (s)]
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dNDkj(s)dM
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dNDkj(s)
]
dMCi (u) + op(1).













Since Rj(s, β0, w
C(s, θ0) converges to r
(0)(s, β0, θ0), n











dMDij (s) + op(1)(4.12)



























which is a sum of independent and identically distributed mean 0 random variates.

















converges to a mean 0 Gaussian process with covari-




ij(t, β0, θ0)] for any set pair of (s, t), where
ξφij(s, β0, θ0) is defined as in Theorem 1.
Proof of Theorem 2
Using the continuous mapping theorem, Ŝj(t, β̂, ŵ
C(θ̂)) = exp{−Λ̂j(t, β̂, ŵ
C(θ̂))}
converges almost surely to Sj(t) = E[S(t|Gi = j,Zi(0))], Therefore, R̂Rj(t) con-
verges almost surely to RRj(t).
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which is a sum of independent and identically distributed mean 0 random variables.









converges to a mean 0 Gaussian process with




ij(t, β0, θ0)], where ξ
R
ij(s, β0, θ0) is de-
fined as in (4.8).
Proof of Theorem 3
Since Ŝj(s, β̂, ŵ
C(θ̂)) converges to Sj(t), using continuous mapping theorem, we ob-









cordingly, ∆̂j(t) converges to ∆j(t).
















S0(s)Φi0(s, β0, θ0)ds + op(1),
which is a sum of independent and identically distributed mean 0 random variables.
Demonstration of normality and weak convergence to a zero mean Gaussian process
is similar as that of Theorem 1.
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This dissertation proposes three novel methods for estimating the cumulative
treatment effect for time to event data in the setting when the treatment-specific
hazards are not proportional. These methods were motivated by research questions
on organ failure data. Therefore, the contribution of this research is not only statis-
tical but also clinical. Chapter 2 used the ratio of cumulative hazards to compare
treatment categories. Chapter 3 considered the setting where, in addition to the
treatment effect, the effect of the adjustment covariates may be non-proportional.
In addition to accommodating non-proportionality and unbalanced covariate distri-
bution among treatment groups, Chapter 4 handled the dependent censoring due to
time-dependent covariates.
Through a stratified Cox model, the method in Chapter 2 proposed the ratio of
cumulative hazards as a treatment effect measure suited to the setting where the
treatment effect varies over time. The proposed measure has the familiar hazard
ratio interpretation when proportional hazards holds. Methods proposed in both
Chapter 3 and Chapter 4 applied inverse probability of treatment weighting (IPTW)
to balance the distribution of adjustment covariates among treatment groups. An
inverse probability of censoring weight (IPCW) was applied to deal with dependent
104
105
censoring in Chapter 4. Chapters 3 and 4 compared cumulative hazards, relative
risk, and restricted mean lifetime between treatment categories.
Each method was applied to organ failure data. In Chapter 2 and Chapter 3,
we found that patients with end-stage renal disease who were treated by peritoneal
dialysis have a lower cumulative hazard at the beginning but higher hazard in the
long term compared to those treated by hemodialysis. In Chapter 4, we found that
Caucasians on the kidney transplant wait list have shorter restricted mean lifetime
than African Americans in the long term. This result is consistent with the current
literature.
The methods proposed in this dissertation could be extended in several directions.
For example, the methods in each of Chapters 2 to 4 focused on a treatment assigned
at baseline (time 0). It would be interesting to develop methods to estimate the
cumulative effect of a time-dependent treatment. Additionally, the survival time was
assured to be univariate. The extension of the proposed methods to accommodate
multivariate failure time data (e.g., recurrent events) would be valuable.
